UNITED STATES

 SECURITIES AND EXCHANGE COMMISSION

 Washington, D.C. 20549

 FORM 10-K

 ANNUAL REPORT PURSUANT TO SECTION 13
OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 For the fiscal year ended December 31, 2024

 TRANSITION REPORT PURSUANT TO SECTION
13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 For the transition period from ________ to _________

 Commission file number 000-56253

 (Exact name of registrant as specified in charter)

 Delaware

 26-2274999

 (State or jurisdiction of

Incorporation or organization)

 I.R.S Employer

Identification No.

 20 Raul Wallenberg Street, Tel Aviv, Israel

 6971916

 (Address of principal executive offices)

 (Zip code)

 (678) 558-5564

 (Registrant's telephone number, including
area code)

 Securities registered pursuant to Section 12(b)
of the Act: None.

 Securities registered pursuant to Section 12(g)
of the Act: Common Stock, par value $0.0001 per share.

is a well-known seasoned issuer as defined in Rule 405 of the Securities Act. Yes No

 Indicate by check mark if the registrant is not
required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes No

(1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months
(or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements
for the past 90 days. Yes No

has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405
of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
 Yes No

is a large accelerated filer, an accelerated filer, or a non-accelerated filer, a smaller reporting company, or an emerging growth company.
See definition of "large accelerated filer," "accelerated filer," "smaller reporting company," and
"emerging growth company" in Rule 12b-2 of the Exchange Act.

 Large accelerated filer

 Accelerated filer

 Non-accelerated filer

 Smaller Reporting Company

 Emerging Growth Company

 If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.

has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial
reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or
issued its audit report.

 If securities are registered pursuant to Section
12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction
of an error to previously issued financial statements.

 Indicate by check mark whether any of those error
corrections are restatements that required a recovery analysis of incentive- based compensation received by any of the registrant's
executive officers during the relevant recovery period pursuant to §240.10D-1(b).

is a shell company (as defined by Rule 12b-2 of the Exchange Act) Yes No

 The aggregate market value of voting and non-voting
common equity held by non-affiliates of the registrant as of December 31, 2024, the last business day of the registrant's most recently
completed second fiscal quarter, was approximately $ 2.2 million.

 The number of shares of common stock outstanding
as of December 31, 2024, was 9,830,948.

 Documents Incorporated by Reference: None.

 Item 1.

 Business

 Item 1A.

 Risk Factors

 Item 1B.

 Unresolved Staff Comments

 Item 1C.

 Cybersecurity

 Item 2.

 Properties

 Item 3.

 Legal Proceedings

 Item 4.

 Mine Safety Disclosures

 Item 5.

 Market For Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

 Item 6.

 [Reserved]

 Item 7.

 Management's Discussion and Analysis of Financial Condition and Results of Operations

 Item 7A.

 Quantitative and Qualitative Disclosures about Market Risk

 Item 8.

 Financial Statements and Supplementary Data

 Item 9.

 Changes in and Disagreements With Accountants on Accounting and Financial Disclosure

 Item 9A.

 Controls and Procedures

 Item 9B.

 Other Information

 Item 9C.

 Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.

 Item 10.

 Directors, Executive Officers and Corporate Governance

 Item 11.

 Executive Compensation

 Item 12.

 Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

 Item 13.

 Certain Relationships and Related Transactions, and Director Independence

 Item 14.

 Principal Accounting Fees and Services

 FF-1

 Item 15.

 Exhibits, Financial Statement Schedules

 FF-1

 Signatures

 i

 In this Annual Report on Form 10-K, unless the
context requires otherwise, the terms "we," "our," "us," "the Company," or "Charging
Robotics" refer to Charging Robotics Inc. (formerly Fuel Doctor Holdings, Inc.), a Delaware corporation, and its wholly-owned subsidiary,
Charging Robotics, Ltd., an Israeli company, and references to "CR Israel" refer to Charging Robotics, Ltd.

 References to "U.S. dollars" and "$"
are to currency of the United States of America, and references to "NIS" are to New Israeli Shekels. Unless otherwise indicated,
U.S. dollar translations of NIS amounts presented in this Annual Report on Form 10-K for the year ended on December 31, 2024, are translated
using the rate of NIS 3.647 to $1.00, based on the exchange rate reported by the Bank of Israel on that date.

 CAUTIONARY NOTE ON FORWARD-LOOKING STATEMENTS

 This Annual Report on Form 10-K contains "forward-looking
statements." In some cases, you can identify forward-looking statements by terminology such as "may", "will",
"should", "could", "expects", "plans", "intends", "anticipates",
"believes", "estimates", "predicts", "potential" or "continue" or the negative
of such terms and other comparable terminology. These forward-looking statements include, without limitation, statements about our market
opportunity, our strategies, competition, expected activities and expenditures as we pursue our business plan, and the adequacy of our
available cash resources. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot
guarantee future results, levels of activity, performance or achievements. Actual results may differ materially from the predictions discussed
in these forward-looking statements. The economic environment within which we operate could materially affect our actual results. Additional
factors that could materially affect these forward-looking statements and/or predictions include, among other things: the Company's
need for and ability to obtain additional financing, security, political and economic instability in the Middle East that could harm our
business, including due to the security situation in Israel, and the demand for the Company's products, and other factors over which
we have little or no control; and other factors discussed in the Company's filings with the Securities and Exchange Commission ("SEC").

 The foregoing sets forth some, but not all, of
the factors that could affect our ability to achieve results described in any forward-looking statements. You should read this Annual
Report on Form 10-K and the documents that we reference herein and have filed as exhibits to the Annual Report on Form 10-K, completely
and with the understanding that our actual future results may be materially different from what we expect. You should assume that the
information appearing in this Annual Report on Form 10-K is accurate as of the date hereof. Because the risk factors referred to in this
Annual Report on Form 10-K, could cause actual results or outcomes to differ materially from those expressed in any forward-looking statements
made by us or on our behalf, you should not place undue reliance on any forward-looking statements.

 Further, any forward-looking statement speaks
only as of the date on which it is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances
after the date on which the statement is made or to reflect the occurrence of unanticipated events. New factors emerge from time to time,
and it is not possible for us to predict which factors will arise. In addition, we cannot assess the impact of each factor on our business
or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any
forward-looking statements. We qualify all of the information presented in this Annual Report on Form 10-K, and particularly our forward-looking
statements, by these cautionary statements.

 ITEM 1. BUSINESS

 About Charging Robotics

 Charging Robotics is engaged in the development,
production and installation of wireless charging systems for various applications. The current focus of the company is wireless charging
systems for electric vehicles (EVs) in robotic parking systems. The Company believes that this solves a very strong need for not being
able to use cable based charging systems in these kinds of parking systems. At the heart of the technology is a wireless power transfer
module that uses resonance induction coils to transfer electricity wirelessly. This module can be used for various products such as robotics
and stationary platforms. These coils are installed in various places of the parking facility and when the robotics parking system stores
a vehicle to be parked, the wireless charging system detects this and automatically starts to charge the car in a wireless manner.

 CR Israel was founded in February 2021 with the
goal of developing a robotics system (of our own) to wirelessly charge electric vehicles in regular parking lots. The robotic platform
that we developed includes a component which is small enough to fit under the vehicle and charge it wirelessly. The robot will automatically
position itself for maximum-efficiency charging, and upon completion will automatically return to its docking station or to charge the
next vehicle. We have developed this concept and have a working prototype for it, proving its feasibility. Our focus on wireless charging
for robotics parking systems began in in June 2023, since we found this market niche to be both large enough and much closer to market
due to the R&D required, the bigger market needs and the better product market fit. Automatic or robotic parking systems (APSs) are
used to store vehicles automatically, when a driver arrives at the parking facility, and retrieve them when such driver wishes to depart.
The vehicles are stored in areas with no human access, which makes charging an EV using the traditional cable-and-plug system impractical,
since drivers cannot reach their vehicles in order to connect the plug. The Company's innovative solution utilizes wireless electrical
transfer modules that do not require the driver to connect a plug in a place with no access. The Company's solution is used to transfer
electricity wirelessly from the building's electrical grid to the vehicle (or alternatively, to a carrier plate on which the vehicle
is located). This will enable EVs to charge in "no access" areas of APSs. Currently, the Company successfully completed a
pilot project in Tel Aviv and is currently working towards delivery of the first purchased systems to be installed in automatic parking
facilities in Tel Aviv.

 On April 24, 2021, Charging Robotics invested
$250,000 and purchased 19.99% of the share capital of Revoltz Ltd. ("Revoltz"), an Israeli private company focusing on research,
development and production of micro-mobility vehicles for the urban environment for the business and the private markets. On March 27,
2024, Revoltz announced a $2.7 million exclusive distribution agreement with the completion of the first batch production of 50 PORTO
Micro-Mobility EVs for the last-mile delivery market. Completing the production is a significant step in Revoltz's preparation for
its first shipment in accordance with the distribution agreement it signed this past year.

 Revoltz has made significant strides in the EV
industry with the launch of PORTO, which provides a seamless blend of functionality, sturdy design, and agility, designed specifically
for the growing last-mile delivery market. The PORTO vehicle, capable of 100 km with a delivery payload of 250L on a single charge, offers
a similar payload capacity to a small hatchback car, at a fraction of the cost and with the ability to maneuver in tight urban environments.
PORTO uses an advanced tilting suspension mechanism, ensuring best-in-class stability, even bearing a full load. With high volume loading
spaces integrated over both axles, the cargo weight is distributed evenly, making for a safe and confident ride with unmatched vehicle
dimensions.

 The EV Market

 The EV market is growing globally, due to favorable
government policies and support (e.g., subsidies and grants), growing sensitivity toward a cleaner environment and demand for zero-emission
vehicles, and resulting heavy investments in R&D from vehicle manufacturers. EV market growth requires charging infrastructure to
grow as well. EV chargers are used to provide charging to EVs with a battery and the electrical source that helps to charge the battery.
Currently the most common and leading solution are charging cables. Under a scenario where EV will hit 30% market share by 2030, the International
Energy Agency forecasts that as many as 30 million public chargers would be needed to serve regular passenger vehicles – a number
50 times more than today's installation-based vehicles.

 We aim to become world's first wireless
charging solution that is set on an autonomous robot, for seamless charging experience. Our growth strategy is to primarily focus on public
parking lots. Later in our growth strategy we aim to address private mass markets. In addition to entering markets with our technology,
we aim to expand our development, design, and manufacturing capabilities.

 Industry Overview and Market Challenges

 After entering commercial markets in the first
half of the decade, EV sales have soared to 7.2M vehicles in 2019, surpassing 2018 – already a record year. According to updated
forecast reports from Statista, the unit sales of the EV market are anticipated to reach 18.84m vehicles units by 2029.

 In 2025, the revenue in the Electric
Vehicles market is projected to reach a staggering US$828.6bn worldwide. Looking ahead, it is expected that the market will
demonstrate a steady compounded annual growth rate (CAGR) of 6.95% from 2025-2029, and according to some research entities,
developing public charging infrastructures to meet the demand is a key challenge to the EV industry.

 The lack of sufficient charging stations, particularly
in rural and suburban areas, continues to challenge EV adoption. According to an ongoing study by the California Energy Commission and
the University of California Davis, almost 30% of EV charge attempts have failed for reasons such as charger congestion, damaged chargers,
and difficulty locating the charging stations. While urban centers see improvements, the industry needs widespread infrastructure
to provide convenient charging options.

 Some countries are also taking major actions to
face the challenge of EV charging. By way of example, the U.S. Bipartisan Infrastructure Law passed in November 2021, and includes
a budget of $7.2 billion, designated solely to EV charging infrastructure.

 Currently, the main charging solution that is
adopted globally is cable charging. But this is about to change. Wireless charging technology for the automotive industry is expected
to be the fastest growing segment of the wireless charging solutions entire market by the year 2027.

 The automotive wireless charging market is highly driven by an increase
in sales of EVs and their demand for the safer, convenient, and faster wireless charging system compared to cables.

 According to recent research companies, the global
wireless EV charging market is expected to reach some 568 billion U.S. dollars by 2030. According to this source wireless recharging is
currently not faster, but it may be more accessible. Inductive chargers use electromagnetic oscillations to efficiently produce electric
current that recharges a battery, without the need to plug in any wires.

 EV charging, which will eventually replace the
traditional method of connecting the car to a power source. EVs may eventually be able to function similarly to conventional internal
combustion engine (ICE) vehicles thanks to wireless or inductive charging.

 The market is anticipated to be driven by increasing
EV demand, wireless technology R&D, and the implementation of fast-charging infrastructure.

 Our Solution

 Our current product which was pilot tested with
an APS supplier in Israel is a system that wirelessly charges EVs in APSs. Upon arrival at the APS, the driver parks the EV on a plate
used by the APS to transport the EV to the final parking location. The EV remains on the plate until it is retrieved by the APS and the
driver enters the EV departs. When a driver parks an EV on these chagrining plates, they connect a regular charging cable to a socket
installed on the plate, at which point the plate moves through the APS via conveyors and elevators to the parking location. Our system
is installed in two parts. The electricity receiving component is installed on the plate and consists of a receiving coil and supporting
electronics and a socket where the driver connects a cable to the charging socket of the EV. The system's transmitting component
is installed in the APS facility and consists of a transmitting coil and the supporting electronics. As the driver parks the EV and connects
the cable from the plate to the EV, he initiates that charging using our mobile application. Once initiated, the system goes into standby
mode. Upon the plate arriving at its final parking location, charging of the EV begins. When the plate and EV are in the final parking
position, the transmitting coil and the receiving coil are in proximity and by way of electromagnetic induction, electricity passes from
the stationary part (transmitting) of the system to the moving (receiving) part of the system. This enables the charging of EVs in places
where drivers can not enter and manually connect a plug.

 Although we have decided to currently focus on
the solution for APSs, longer term future products will include the robotic solutions on which the Company was founded. We have succeeded
in developing a tethered robotic solution. This robot was intended to charge an EV of a disabled driver and offer an automatic method
for wireless charging of EVs. This solution will offer a big benefit for disabled drivers who have difficulty using a regular plug-and-cable-based
charger. For these drivers, it is merely impossible to exit the EV, go to the charger, take the cable and connect the plug to the EV.
Using our solution, charging will be performed automatically using the tethered robot. As the driver parks the EV, that robot will recognize
the EV and will automatically navigate under the EV and charge it wirelessly. For this we have developed a patent-pending technology to
navigate to the EV using data obtained by lidar (laser-based) sensors viewing only the EV's wheels.

 Competition

 Wireless charging solutions that are currently
being developed are usually in the form of a pad or surface. Companies developing such technology include Robert Bosch GmbH (Germany),
Continental AG (Germany), WiTricity Corporation (U.S.), ZTE Corporation (China), and HELLA KGaA Hueck & Co. (Germany), Qualcomm Technologies
Inc./WiTricity Corporation, to name a few.

 Below is a competitive analysis of our solution
in comparison to other EV charging technologies, either existing or currently in development. Analysis is based on the Company's
best knowledge and understating.

 Strategy and Business Model

 Our goal is to become a global leader in EV wireless
charging by providing efficient, effortless, affordable, and scalable solutions. We intend to achieve our goal by implementing the following
strategies:

 B2B channel as a market penetration. Our
go-to-market strategy is based on offering our solutions on a B2B basis. We intend to market our solution to owners and/or operators of
public parking spaces of many varieties, such as shopping malls, office buildings, entertainment centers, hospitals, sports centers etc.

 Variety of business models. The
Company will sell three different products, each utilizing different business models:

 1.

 EV Wireless Charging System. These systems will be used to charge vehicles in APSs. These systems will be sold to the end-user as capital equipment with payment at the installation of the system and recurring revenues for services after the warranty period has concluded.

 2.

 Software as a Service (SaaS). The user interface that is used to operate our system is developed in cooperation with Make My Day (a company specializing in app development for EV fleet management). This user interface is used by the driver to get recommendations for a driving route that optimizes EV electricity consumption, and also has functions which assist the driver in utilizing our system upon arrival to an APS. Based on the benefits that this solution provides drivers, we intend to monetize it to generate another revenue stream by way of subscription fees and/or advertisements once we've sufficiently scaled to reach a wider driver audience.

 3.

 Electricity for Charging. We may offer a service of EV charging using our proprietary wireless charging system. We will offer the driver a service that ensures that their vehicle is always charged when parked over our charger. For this we will install our systems at the parking facility and we will use them to charge the vehicles. The driver will be offered various plans for purchasing electricity from us. One option can be a fixed price that ensures the car is always charged, another is an option to pay for the electricity purchased and many others. For this we will purchase electricity from the power utility at better rates (due to economies of scale) and we will use our wireless charging systems to sell electricity to the driver at a profit. We will also be able to install electricity storage system for increasing this profit by purchasing electricity at low rates, storing it and selling it at peak demand times at a premium. The main benefit of this business model is that it offers a recurring revenue stream for the company.

 We intend to offer these different types of business
models to increase our technology adoption. Such business models are selling robots to end users, operating the robots and generating
revenues from selling electricity, renting robots to end users and charging a subscription fee for the app used to optimize EV battery
usage.

 Addressing niche markets that require alternative
to cable charging. Since the foundation of our Company, we came across other potential niche EV charging markets that are
in search for alternatives to traditional cable-based charging. As mentioned above, a prime example where our solution could make a significant
difference for users is with respect to charging stations for handicap people. Our robotic technology could potentially be a unique and
optimal solutions for EV handicap people who struggle with cable charging for their EVs.

 Cooperation with EV charging infrastructure
companies and EV manufacturers. Part of our strategy is to establish cooperation or joint ventures with EV charging infrastructure
companies and EV manufacturers. We believe that, with such partnerships, we could work on additional robotic-based solutions, enhance
relevant robot or charging capabilities and create faster go-to-market channels.

 Building a brand. We believe
the Company can become a global known brand for robotic charging solutions. We intend to make significant efforts in growing our brand
recognition and building a global market footprint and market position.

 Government Regulation

 We are subject to the same regulations as regular
charging stations. Since governments are globally playing a major role in the growth of the EV Supply Equipment market, as they mandate
policies and set targets related to the adoption of EVs and charging infrastructure, there are markets where more regulation has
the potential to positively impact our growth and success. We intend to focus on these markets and countries where we believe regulation
could boost adoption of our solution and our sales.

 Intellectual Property

 We currently own several intellectual property
(IP) assets, at various stages. In the past we held an exclusive license to some patents owned by the Ben Guryon University but we terminated
this agreement in the last year. The following table summarizes our IP assets as of the date of this annual report:

 Patent Title or Published Patent Application Title

 Jurisdiction

 Estimated

Expiration

 System and method for Wireless Vehicle Battery Charging

 US

 2041

 System and method for Wireless Vehicle Battery Charging

 US

 2041

 Wireless Charging in Automated Parking Garages

 PCT

 2042

 A Method for Introducing An Autonomous or Partially Autonomous Robot Under A Parked Vehicle

 US prov.

 2043

 We also rely on trade secrets, know-how, and continuous
innovation to develop and maintain our competitive position. We cannot be certain that patents will be granted with respect to any patent
applications filed by us in the future, nor can we be assured that any patents granted to us in the future will be commercially useful
in protecting our technology.

 Our success depends, in part, on an IP portfolio
that supports future revenue streams and erects barriers to our competitors.

 Despite these measures, any of our IP and proprietary
rights could be challenged, invalidated, circumvented, infringed or misappropriated. IP and proprietary rights may not be sufficient to
permit us to take advantage of current market trends or otherwise to provide competitive one.

 Employees

 Currently, we have two senior management positions
(CEO and CFO), who we engage in part-time capacities via consulting agreements. In addition, we have four engineers working for us as
part-time consultants. All of our engineers and management are located in Israel. At present we do not employ any of our personnel, and
none are represented by labor unions or covered by collective bargaining agreements. We believe that we maintain good working relationships
with our management and our engineers. As a result of Charging Robotics being located in Israel, to the extent that we enter into employment
agreements, we will be subject to certain Israeli labor laws, regulations and national labor court precedent rulings, as well as certain
provisions of collective bargaining agreements applicable to us by virtue of extension orders issued in accordance with relevant labor
laws by the Israeli Ministry of Economy and which apply such agreement provisions to our employees even though they are not part of a
union that has signed a collective bargaining agreement.

 All of our consulting agreements include undertakings
by our personnel with respect to confidentiality, non-competition and assignment to us of IP rights developed in the course of their engagement.
Our consulting agreement with our CEO includes provisions with respect to assignment to us of intellectual property rights developed in
the course of employment and confidentiality. The enforceability of such provisions is subject to Israeli law.

 Properties

 Our corporate headquarters are located at 20
Raul Wallenberg Street, Tel Aviv, Israel 6971916, under a lease held by our shareholders, free of rent to the company. In January
2025, the Company rented an office, lab and assembly and integration area in an innovation and startup hub located in "The
Rupin Technological Campus", approximately 40km north of Tel Aviv. The monthly rental fee is 4,000 NIS (approximately $1,100)
per month. The lease term requires only one month termination notice.

 Legal Proceedings

 We are not aware of any pending or threatened
legal proceedings involving our Company or its assets.

 Company Information

 Our principal executive offices are located at
20 Raul Wallenberg Street, Tel Aviv, Israel 6971916, and our telephone number is (678) 558-5564. Our website address is www.chargingrobotics.com.
Any information contained on, or that can be accessed through, our website is not incorporated by reference into, nor is it in any way
a part of, this Annual Report on Form 10-K.

 We use our website ( www.chargingrobotics.com)
as a channel of distribution of Company information. The information we post through this channel may be deemed material. Accordingly,
investors should monitor our website, in addition to following our press releases, SEC filings and public conference calls and webcasts.
The contents of our website are not, however, a part of this Annual Report on Form 10-K.

 Corporate History

 Charging Robotics Inc. (was incorporated in the
State of Delaware on March 25, 2008, as Silver Hill Management Services, Inc. On August 24, 2011, the Company amended its Certificate
of Incorporation and changed its name to Fuel Doctor Holdings, Inc., and on April 23, 2024, the Company changed its name to Charging Robotics
Inc.

 CR Israel was formed in February 2021, as an Israeli
corporation, with the main goal of developing an innovative wireless electric vehicles (EV) charging technology. At the heart of the technology
is a wireless power transfer module that uses resonance coils to transfer electricity wirelessly. This module can be used for various
products such as robotic and stationary platforms. The robotic platform includes a component which is small enough to fit under the vehicle,
and which automatically positions itself for maximum-efficiency charging, and upon charging completion automatically returns to its docking
station. CR Israel also developed a Wireless EV Charging System for automatic parking lots based on our wireless electricity transfer
module.

 On March 28, 2023, the Company entered into a Securities Exchange Agreement
(the "Acquisition Agreement") with the stockholders of Charging Robotics Ltd. ("Charging Robotics"). Pursuant
to the Acquisition Agreement, at the closing, which occurred on April 7, 2023 (the "Closing"), the Company acquired 100% of
the issued and outstanding stock of Charging Robotics (the "Acquisition"), making Charging Robotics a wholly owned subsidiary
of the Company, in exchange for the issuance of a total of 6,146,188 newly-issued shares of the Company's common stock to
the former shareholders of Charging Robotics.

 On
April 6, 2023, the Company issued a total of 910,000 newly issued shares of common stock of the Company, par value $0.0001 per share,
in respect of a private placement for total proceeds of $501 thousand.

 On August 28, 2023, the
Company filed an amended and restated certificate of incorporation (the "Amended and Restated Certificate of Incorporation"),
to (i) change its name to Charging Robotics Inc. (the "Name Change"); and (ii) effect a one-for-one hundred fifty reverse
stock split (the "Reverse Stock Split") of its outstanding shares of common stock. Also on August 28, 2023, the Company submitted
an Issuer Company-Related Action Notification Form to the Financial Industry Regulatory Authority, Inc. ("FINRA") regarding
the Name Change and Reverse Stock Split. On April 23, 2024, the Company received notice from FINRA that the Name Change and the Reverse
Stock Split was announced on FINRA's daily list and would take effect at market open on the Market Effective Date. Accordingly,
the FINRA corporate action to effect the Name Change and the Reverse Stock Split was completed on April 23, 2024.

 On November 22, 2023, the Company announced that
CR Israel received approval for funding from the Israel Innovation Authority (the "IIA") for a pilot project to include installing
and demonstrating its solution for wireless charging of electric vehicles (EVs) in automated parking systems ("APS"). The
total approved budget for this project was approximately $445 thousand, of which the IIA would finance 50%. The Company is now engaged
in the pilot project to implement the solution in an APS in Tel Aviv. As of December 31, 2024, CR Israel received a total of $136 thousand
from the IIA.

 On December 2, 2024, the Inc. filed another amended and restated certificate
of incorporation, to reduce the Company's authorized shares of common stock from 2,990,000,000 to 50,000,000.

 In December 2024, the Company sold a total of 412,123 newly issued
shares of common stock to a total of seven investors for a total of $410,000.

 On January 15, 2025, the Company sold a total of 30,303 newly issued
shares of common stock to a total of seven investors for a total of $50,000.

 ITEM 1A. RISK FACTORS

 An investment in our common stock involves a high
degree of risk. You should carefully consider the following risk factors and the other information in this Annual Report on Form 10-K
before investing in our common stock. Our business and results of operations could be seriously harmed by any of the following risks.
The risks set out below are not the only risks we face. Additional risks and uncertainties not currently known to us or that we currently
deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results. If any of the following
events occur, our business, financial condition and results of operations could be materially adversely affected. In such case, the value
and trading price of our common stock could decline, and you may lose all or part of your investment.

 Summary Risk Factors

 The principal factors and uncertainties that make
investing in our common stock risky, include, among others:

 Risks Related to Our Financial Condition and
Capital Requirements

 We are a development-stage company and have a
limited operating history on which to assess the prospects for our business, have incurred significant losses since the date of our inception,
and anticipate that we will continue to incur significant losses until we are able to successfully commercialize our products.

 Our financial statements contain a going concern
note regarding substantial doubt about our ability to continue as a going concern, which could prevent us from obtaining new financing
on reasonable terms or at all.

 We have not generated any significant revenue
from the sale of our current products and may never be profitable.

 We expect that we will need to raise substantial
additional capital before we can expect to become profitable from sales of our products. This additional capital may not be available
on acceptable terms, or at all. Failure to obtain this necessary capital when needed may force us to delay, limit or terminate our product
development efforts or other operations.

 Our operating results and financial condition
may fluctuate.

 Risks Related to Our Business and Industry

 We operate in an evolving market which makes
it difficult to evaluate our business and future prospects.

 We face uncertainty and adverse changes in the
economy.

 We depend on key personnel to operate our business.
An inability to retain, attract, and integrate qualified personnel would harm our ability to develop and successfully grow our business.

 If we fail to manage rapid growth effectively,
our brand, business, financial condition and results of operations could be adversely affected.

 If critical components or raw materials used
to manufacture our products become scarce or unavailable, then we may incur delays in manufacturing and delivery of our products, which
could damage our business.

 Our products may be subject to recall or returns.

 If we release defective products or services,
our operating results could suffer.

 Our products and services are complex and could
have unknown defects or errors, which may give rise to legal claims against us, diminish our brand or divert our resources from other
purposes.

 The markets in which we plan to compete are characterized
by rapid technological change, which requires us to develop new products and product enhancements, and could render our existing products
obsolete.

 If we fail to successfully promote our products
and brand, this could have a material adverse effect on our business, prospects, financial condition and results of operations.

 Our planned international operations will expose
us to additional market and operational risks, and failure to manage these risks may adversely affect our business and operating results.

 Significant disruptions of our information technology
systems or breaches of our data security could adversely affect our business.

 We rely on business partners, and they may be
given access to sensitive and proprietary information in order to provide services and support to our customers.

 We may be subject to electronic communication
security risks.

 Risks Related to Our Intellectual Property

 If we are unable to obtain and maintain effective
intellectual property rights for our products, we may not be able to compete effectively in our markets.

 Intellectual property rights of third parties
could adversely affect our ability to commercialize our products, and we might be required to litigate or obtain licenses from third parties
in order to develop or market our product candidates. Such litigation or licenses could be costly or not available on commercially reasonable
terms.

 We may be involved in lawsuits to protect or
enforce our intellectual property, which could be expensive, time consuming, and unsuccessful.

 We may be subject to claims challenging the inventorship
of our intellectual property.

 We may not be able to protect our intellectual
property rights throughout the world.

 We may become subject to claims for remuneration
or royalties for assigned service invention rights by our employees, which could result in litigation and adversely affect our business.

 Risks Related to Our Common Stock

 We are an "emerging growth company"
and our compliance with the reduced reporting and disclosure requirements applicable to "emerging growth companies" may make
our common stock less attractive to investors.

 If we fail to maintain effective internal controls
over financial reporting, the price of our common stock may be adversely affected.

 Compliance with changing regulation of corporate
governance and public disclosure will result in additional expenses.

 Our common stock may be considered a "penny
stock," and thereby be subject to additional sale and trading regulations that may make it more difficult to sell.

 We may be subject to securities litigation, which
is expensive and could divert management attention.

 If securities or industry analysts do not publish
or cease publishing research or reports about us, our business or our market, or if they adversely change their recommendations or publish
negative reports regarding our business or our shares, our share price and trading volume could decline.

 We have no operating experience as a publicly
traded company in the United States.

 Raising additional capital will cause dilution
to our existing stockholders and may affect the rights of existing stockholders.

 Sales of a substantial number of shares of our
common stock in the public market by our existing stockholders could cause our share price to fall.

 We have never paid, and we currently do not intend
to pay dividends.

 Risks Related to Our Location and Operations
in Israel

 We are exposed to fluctuations in currency exchange
rates.

 Our headquarters, research and development and
other significant operations are located in Israel, and, therefore, our results may be adversely affected by political, economic and military
instability in Israel.

 Our operations may be disrupted as a result of the obligation
of management or key personnel to perform military service.

 Risks Related to Our Financial Condition and
Capital Requirements

 We are a development-stage company and have
a limited operating history on which to assess the prospects for our business, have incurred significant losses since the date of our
inception, and anticipate that we will continue to incur significant losses until we are able to successfully commercialize our products.

 We
are a development-stage company with a limited operating history. We have incurred net losses since our inception, including net losses
of approximately $842 thousand for the year ended December 31,
2024. As of December 31, 2024, we had accumulated losses of approximately $2.9 million.

 We have devoted most of our financial resources
to developing our products. The amount of our future net losses will depend, in part, on completing the development of our products, the
rate of our future expenditures and our ability to obtain funding through the issuance of our securities, strategic collaborations or
grants. We expect to continue to incur significant losses until we are able to successfully commercialize our products. We anticipate
that our expenses will increase substantially if and as we:

 continue the development of our products;

 establish a sales, marketing, distribution and technical support infrastructure to commercialize our products;

 seek to identify, assess, acquire, license, and/or develop other products and subsequent generations of our current products;

 seek to maintain, protect, and expand our intellectual property portfolio;

 seek to attract and retain skilled personnel; and

 create additional infrastructure to support our operations as a public company and our product development and planned future commercialization efforts.

 Our financial statements contain a
going concern note regarding substantial doubt about our ability to continue as a going concern, which could prevent us from
obtaining new financing on reasonable terms or at all.

 Our audited financial statements for the year ended December 31,
2024, contain a going concern note regarding substantial doubt about our ability to continue as a going concern. This substantial doubt
could materially limit our ability to raise additional funds through the issuance of equity or debt securities or otherwise. Future financial
statements may also include a note with respect to our ability to continue as a going concern. Until we can generate significant recurring
revenues, we expect to satisfy our future cash needs through debt or equity financing. We cannot be certain that additional funding will
be available to us on acceptable terms, if at all. If funds are not available, we may be required to delay, reduce the scope of, or eliminate
research or development plans for, or commercialization efforts with respect to our products. This may raise substantial doubts about
our ability to continue as a going concern.

 We have not generated any revenue
from the sale of our current products and may never be profitable.

 While we have commenced commercialization efforts,
we have not generated any significant revenue since our inception. Our ability to generate revenue and achieve profitability depends on
our ability to successfully complete the development of, and to commercialize, our products. Our ability to generate future revenue from
product sales depends heavily on our success in many areas, including but not limited to:

 completing development of our products;

 establishing and maintaining supply and manufacturing relationships with third parties that can provide adequate (in amount and quality) products to support market demand for our products;

 launching and commercializing products, either directly or with a collaborator or distributor;

 addressing any competing technological and market developments;

 identifying, assessing, acquiring and/or developing new products;

 negotiating favorable terms in any collaboration, licensing or other arrangements into which we may enter;

 maintaining, protecting and expanding our portfolio of intellectual property rights, including patents, trademarks, trade secrets and know-how; and

 attracting, hiring and retaining qualified personnel.

 We expect that we will need to raise substantial
additional capital before we can expect to become profitable from sales of our products. This additional capital may not be available
on acceptable terms, or at all. Failure to obtain this necessary capital when needed may force us to delay, limit or terminate our product
development efforts or other operations.

 We expect that we will require substantial additional
capital to commercialize our products. In addition, our operating plans may change as a result of many factors that may currently be unknown
to us, and we may need to seek additional funds sooner than planned. Our future capital requirements will depend on many factors, including
but not limited to:

 the scope, rate of progress, results and cost of product development, and other related activities;

 the cost of establishing commercial supplies of our products;

 the cost and timing of establishing sales, marketing, and distribution capabilities; and

 the terms and timing of any collaborative, licensing, and other arrangements that we may establish.

 Any additional fundraising efforts may divert
our management from their day-to-day activities, which may adversely affect our ability to develop and commercialize our products.
In addition, we cannot guarantee that future financing will be available in sufficient amounts or on terms acceptable to us, if at all.
Moreover, the terms of any financing may adversely affect the holdings or the rights of our shareholders and the issuance of additional
securities, whether equity or debt, by us, or the possibility of such issuance, may cause the market price of our common stock to decline.
The incurrence of indebtedness could result in increased fixed payment obligations, and we may be required to agree to certain restrictive
covenants, such as limitations on our ability to incur additional debt, limitations on our ability to acquire, sell or license intellectual
property rights and other operating restrictions that could adversely impact our ability to conduct our business. We could also be required
to seek funds through arrangements with collaborative partners or otherwise at an earlier stage than otherwise would be desirable, and
we may be required to relinquish rights to some of our technologies or products or otherwise agree to terms unfavorable to us, any of
which may have a material adverse effect on our business, operating results and prospects. Even if we believe that we have sufficient
funds for our current or future operating plans, we may seek additional capital if market conditions are favorable or if we have specific
strategic considerations.

 If we are unable to obtain funding on a timely
basis, we may be required to significantly curtail, delay or discontinue one or more of our research or development programs or the commercialization
of our products or be unable to expand our operations or otherwise capitalize on our business opportunities, as desired, which could materially
affect our business, financial condition and results of operations.

 Our operating results and financial condition
may fluctuate.

 Even if we are successful in marketing its products
to the market, our operating results and financial condition may fluctuate from quarter to quarter and year to year and are likely to
continue to vary due to several factors, many of which will not be within our control. If our operating results do not meet the guidance
that we provide to the marketplace or the expectations of securities analysts or investors, the market price of the common stock will
likely decline. Fluctuations in our operating results and financial condition may be due to several factors, including those listed below:

 the degree of market acceptance of our products and services;

 the mix of products and services that we sell during any period;

 long sales cycles;

 changes in the amount that we spend to develop, acquire or license new products, technologies or businesses;

 changes in the amounts that we spend to promote our products and services;

 changes in the cost of satisfying our warranty obligations and servicing our installed base of systems;

 delays between our expenditures to develop and market new or enhanced systems and consumables and the generation of sales from those products;

 development of new competitive products and services by others;

 difficulty in predicting sales patterns and reorder rates that may result from a multi-tier distribution strategy associated with new product categories;

 litigation or threats of litigation, including intellectual property claims by third parties;

 changes in accounting rules and tax laws in relevant jurisdictions;

 changes in regulations and standards;

 the geographic distribution of our sales;

 our responses to price competition;

 general economic and industry conditions that affect end-user demand and end-user levels of product design and manufacturing;

 changes in interest rates that affect returns on our cash balances and short-term investments;

 changes in dollar-shekel exchange rates that affect the value of our net assets, future revenues and expenditures from and/or relating to our activities carried out in those currencies; and

 the level of research and development activities by our company.

 Due to all of the foregoing factors, and the other
risks discussed herein, you should not rely on quarter-to-quarter comparisons of our operating results as an indicator of our future performance.

 Risks Related to Our Business and Industry

 We operate in an evolving market which makes
it difficult to evaluate our business and future prospects.

 Our products are designed to compete in a rapidly
evolving market. The market for alternative automobile charging technologies is in its early stages. Accordingly, our business and future
prospects may be difficult to evaluate. We cannot accurately predict the extent to which demand for its products and services will develop,
if at all. The challenges, risks and uncertainties frequently encountered by companies in rapidly evolving markets could impact our ability
to do the following:

 generate sufficient revenue to reach and maintain profitability;

 acquire and maintain critical market share;

 achieve or manage growth in operations;

 develop and renew existing contracts;

 attract and retain additional engineers and other highly-qualified personnel;

 successfully develop and commercially market new products;

 adapt to new or changing policies and spending priorities of governments and government agencies; and

 access additional capital when required and on reasonable terms.

 If we fail to successfully address these and other
challenges, risks and uncertainties, its business, results of operations and financial condition would be materially harmed.

 We face uncertainty and adverse changes
in the economy.

 Adverse changes in the economy could negatively
impact our business. Future economic distress may result in a decrease in demand for our products and/or a decrease in the demand for
electric vehicles, which could have a material adverse impact on the Company's operating results and financial condition. Uncertainty
and adverse changes in the economy could also increase costs associated with developing products, increase the cost and decrease the availability
of sources of financing, and increase our exposure to material losses from bad debts, any of which could have a material adverse impact
on our financial condition and operating results.

 We depend on key personnel to operate our
business. An inability to retain, attract, and integrate qualified personnel would harm our ability to develop and successfully grow our
business.

 Our success and growth strategy depend on our
ability to attract and retain key management and operating personnel, including skilled developers, marketing personnel, project managers,
product managers and content editors. Our future success depends on our continuing ability to attract, develop, motivate and retain highly
qualified and skilled employees. Qualified individuals are in high demand, and we may incur significant costs to attract and retain them.
Experienced developers and marketing personnel, who are critical to the success of our business, are also in particularly high demand.
Competition for their talents is intense, making it difficult to retain such qualified individuals.

 If we fail to manage rapid growth effectively,
our brand, business, financial condition and results of operations could be adversely affected.

 Rapid growth may impose significant responsibilities
on our management, including the need to identify, recruit and integrate additional employees with relevant expertise, expand the scope
of our current technological platform and invest in improved controls over technology, financial reporting and information disclosure.
If we fail to manage the growth of our business and operations effectively, the quality of our service and the efficiency of our operations
could suffer, which could adversely affect our business, financial condition, and results of operations.

 In addition, our rapid growth may make it difficult
to evaluate our future performance. Our ability to forecast our future results of operations is subject to a number of uncertainties,
including our ability to model future growth. If we fail to achieve the necessary level of efficiency in our company as it grows, or if
we are not able to accurately forecast future growth, our business would be negatively impacted.

 If critical components or raw materials
used to manufacture our products become scarce or unavailable, then we may incur delays in manufacturing and delivery of our products,
which could damage our business.

 We obtain hardware components, various subsystems
and systems from a limited group of suppliers. We do not have long-term agreements with any of these suppliers that obligate it to continue
to sell us components, subsystems, systems or products. Our reliance on these suppliers involves significant risks and uncertainties,
including whether its suppliers will provide an adequate supply of required components, subsystems or systems of sufficient quality, will
increase prices for the components, subsystems or systems and will perform their obligations on a timely basis.

 In addition, certain raw materials and components
used in the manufacture of our products are periodically subject to supply shortages, and its business is subject to the risk of price
increases and periodic delays in delivery. If we are unable to obtain components from third-party suppliers in the quantities and of the
quality that it requires, on a timely basis and at acceptable prices, then it may not be able to deliver its products on a timely or cost-effective
basis to its customers, which could cause customers to terminate their contracts with the Company, increase our costs and seriously harm
our business, results of operations and financial condition. Moreover, if any of our suppliers become financially unstable, then it may
have to find new suppliers. It may take several months to locate alternative suppliers, if required, or to redesign our products
to accommodate components from different suppliers. We may experience significant delays in manufacturing and shipping its products to
customers and incur additional development, manufacturing and other costs to establish alternative sources of supply if we loose any of
these sources or is required to redesign its products. We cannot predict if it will be able to obtain replacement components within the
time frames that it requires at an affordable cost, if at all.

 Our products may be subject to recall or
returns.

 Products are sometimes subject to the recall or
return of their products for a variety of reasons, including product defects, safety concerns, packaging issues and inadequate or inaccurate
labeling disclosure. If any of the Company's equipment were to be recalled due to an alleged product defect, safety concern or for
any other reason, we could be required to incur unexpected expenses of the recall and any legal proceedings that might arise in connection
with the recall. We may lose a significant amount of sales and may not be able to replace those sales at an acceptable margin or at all.
In addition, a product recall may require significant management time and attention. Additionally, product recalls may lead to increased
scrutiny of our operations by regulatory agencies, requiring further management time and attention and potential legal fees, costs and
other expenses.

 If we release defective products or services,
our operating results could suffer.

 Products and services designed and released by
us involve complex software programs and physical products, which are difficult to develop and distribute. While we have quality controls
in place to detect and prevent defects in its products and services before they are released, these quality controls are subject to human
error, overriding, and reasonable resource constraints. Therefore, these quality controls and preventative measures may not be effective
in detecting and preventing defects in our products and services before they have been released into the marketplace. In such an event,
we could be required, or decide voluntarily, to suspend the availability of the product or services, which could significantly harm its
business and operating results.

 Our products and services are complex and
could have unknown defects or errors, which may give rise to legal claims against us, diminish our brand or divert our resources from
other purposes.

 Despite testing, our products have contained defects
and errors and may in the future contain defects, errors or performance problems when first introduced, when new versions or enhancements
are released or even after these products have been used by our customers for a period of time. These problems could result in expensive
and time-consuming design modifications or warranty charges, delays in the introduction of new products or enhancements, significant increases
in our service and maintenance costs, exposure to liability for damages, damaged customer relationships and harm to our reputation, any
of which could materially harm our results of operations and ability to achieve market acceptance. In addition, increased development
and warranty costs could be substantial and could significantly reduce our operating margins.

 The markets in which we plan to compete
are characterized by rapid technological change, which requires us to develop new products and product enhancements, and could render
our existing products obsolete.

 Continuing technological changes in the market
for our products could make its products less competitive or obsolete, either generally or for particular applications. Our future success
will depend upon its ability to develop and introduce a variety of new capabilities and enhancements to its planned product and service
offerings, as well as introduce a variety of new product offerings, to address the changing needs of the markets in which it offers products.
Delays in introducing new products and enhancements, the failure to choose correctly among technical alternatives or the failure to offer
innovative products or enhancements at competitive prices may cause existing and potential customers to purchase our competitors'
products.

 If we are unable to devote adequate resources
to develop new products or cannot otherwise successfully develop new products or enhancements that meet customer requirements on a timely
basis, its products could lose market share, its revenue and profits could decline, and we could experience operating losses.

 If we fail to successfully promote our products
and brand, this could have a material adverse effect on our business, prospects, financial condition and results of operations.

 We believe that brand recognition is an important
factor to its success. If we fail to promote our brands successfully, or if the expenses of doing so are disproportionate to any increased
net sales it achieves, it would have a material adverse effect on our business, prospects, financial condition and results of operations.
This will depend largely on our ability to maintain trust, be a technology leader, and continue to provide high-quality and secure technologies,
products and services. Any negative publicity about us or its industry, the quality and reliability of our technologies, products and
services, our risk management processes, changes to our technologies, products and services, its ability to effectively manage and resolve
customer complaints, its privacy and security practices, litigation, regulatory activity, and the experience of buyers with our products
or services, could adversely affect our reputation and the confidence in and use of our technologies, products and services. Harm
to our brand can arise from many sources, including failure by us or our partners to satisfy expectations of service and quality; inadequate
protection of sensitive information; compliance failures and claims; litigation and other claims; employee misconduct; and misconduct
by our partners, service providers, or other counterparties. If we do not successfully maintain a strong and trusted brand, our business
could be materially and adversely affected.

 Our planned international operations will
expose us to additional market and operational risks, and failure to manage these risks may adversely affect our business and operating
results.

 We expect to derive a substantial percentage of
our sales from international markets. Accordingly, we will face significant operational risks from doing business internationally, including:

 fluctuations in foreign currency exchange rates;

 potentially longer sales and payment cycles;

 potentially greater difficulties in collecting accounts receivable;

 potentially adverse tax consequences;

 reduced protection of intellectual property rights in certain countries, particularly in Asia and South America;

 difficulties in staffing and managing foreign operations;

 laws and business practices favoring local competition;

 costs and difficulties of customizing products for foreign countries;

 compliance with a wide variety of complex foreign laws, treaties and regulations;

 an outbreak of a contagious disease, such as the resurgence of COVID-19, which may cause us, third party vendors and manufacturers and/or customers to temporarily suspend our or their respective operations in the affected city or country;

 tariffs, trade barriers and other regulatory or contractual limitations on our ability to sell or develop our products in certain foreign markets; and

 being subject to the laws, regulations and the court systems of many jurisdictions.

 Significant disruptions of our information
technology systems or breaches of our data security could adversely affect our business.

 A significant invasion, interruption, destruction
or breakdown of our information technology systems and/or infrastructure by persons with authorized or unauthorized access could negatively
impact our business and operations. We could also experience business interruption, information theft and/or reputational damage from
cyber-attacks, which may compromise our systems and lead to data leakage either internally or at our third-party providers. Our systems
are expected to be the target of malware and other cyber-attacks. Although we have invested in measures to reduce these risks, we cannot
assure you that these measures will be successful in preventing compromise and/or disruption of our information technology systems and
related data.

 We rely on business partners, and they may
be given access to sensitive and proprietary information in order to provide services and support to our customers.

 We rely on various business partners, including
third-party service providers, vendors, licensing partners, development partners and licensees, among others, in some areas of our business.
In some cases, these third parties are given access to sensitive and proprietary information in order to provide us services and support.
These third parties may misappropriate our information and engage in unauthorized use of it. The failure of these third parties to provide
adequate services and technologies, or the failure of the third parties to adequately maintain or update their services and technologies,
could result in a disruption to our business operations. Further, disruptions in the financial markets and economic downturns may adversely
affect our business partners and they may not be able to continue honoring their obligations to us. Alternative arrangements and services
may not be available to us on commercially reasonable terms or we may experience business interruptions upon a transition to an alternative
partner or vendor. If we lose one or more significant business partners, our business could be harmed.

 We may be subject to electronic communication
security risks.

 A significant potential vulnerability of electronic
communications is the security of transmission of confidential information over public networks. Anyone who is able to circumvent our
security measures could misappropriate proprietary information or cause interruptions in its operations. We may be required to expend
capital and other resources to protect against such security breaches or to alleviate problems caused by such breaches.

 Risks Related to Our Intellectual Property

 If we are unable to obtain and maintain
effective intellectual property rights for our products, we may not be able to compete effectively in our markets.

 Historically, we have relied on trade secret protection
and confidentiality agreements to protect the intellectual property related to our technologies and products. Our success depends in large
part on intellectual property protection in the United States and in other countries with respect to our proprietary technology and
new products.

 We may seek to protect our proprietary position
by filing patent applications in Israel, the United States and in other countries, with respect to our novel technologies and products,
which are important to our business. Patent prosecution is expensive and time consuming, and we may not be able to file and prosecute
all necessary or desirable patent applications at a reasonable cost or in a timely manner. It is also possible that we will fail to identify
patentable aspects of our research and development output before it is too late to obtain patent protection.

 If we seek patent protection, we cannot offer
any assurances about which, if any, patent applications will issue, the breadth of any such patent or whether any issued patents will
be found invalid and unenforceable or will be threatened by third parties. Any successful opposition to these patents or any other patents
owned by or licensed to us after patent issuance could deprive us of rights necessary for the successful commercialization of any new
products that we may develop.

 Further, there is no assurance that all potentially
relevant prior art relating to our patent applications has been found, which can invalidate a patent or prevent a patent from issuing
from a pending patent application. Even if patents do successfully issue, and even if such patents cover our products, third parties may
challenge their validity, enforceability, or scope, which may result in such patents being narrowed, found unenforceable or invalidated.
Furthermore, even if they are unchallenged, our patent applications and any future patents may not adequately protect our intellectual
property, provide exclusivity for our new products, or prevent others from designing around our claims. Any of these outcomes could impair
our ability to prevent competition from third parties, which may have an adverse impact on our business. If we cannot obtain and maintain
effective patent rights for our products, we may not be able to compete effectively, and our business and results of operations would
be harmed.

 Further, international trade conflicts could have
negative consequences on the demand for our products and services outside Israel. Other risks of doing business internationally include
political and economic instability in the countries of our customers and suppliers, changes in diplomatic and trade relationships and
increasing instances of terrorism worldwide. Some of these risks may be affected by Israel's overall political situation.

 Intellectual property rights of third parties
could adversely affect our ability to commercialize our products, and we might be required to litigate or obtain licenses from third parties
in order to develop or market our product candidates. Such litigation or licenses could be costly or not available on commercially reasonable
terms.

 It is inherently difficult to conclusively assess
our freedom to operate without infringing on third party rights. Our competitive position may be adversely affected if existing patents
or patents resulting from patent applications issued to third parties or other third-party intellectual property rights are held to cover
our products or elements thereof, or our manufacturing or uses relevant to our development plans. In such cases, we may not be in a position
to develop or commercialize products or our product candidates unless we successfully pursue litigation to nullify or invalidate the third-party
intellectual property right concerned or enter into a license agreement with the intellectual property right holder, if available on commercially
reasonable terms. There may also be pending patent applications that if they result in issued patents, could be alleged to be infringed
by our new products. If such an infringement claim should be brought and be successful, we may be required to pay substantial damages,
be forced to abandon our new products or seek a license from any patent holders. No assurances can be given that a license will be available
on commercially reasonable terms, if at all.

 It is also possible that we have failed to identify
relevant third-party patents or applications. Patent applications in the United States and in most of the other countries are published
approximately 18 months after the earliest filing for which priority is claimed, with such earliest filing date being commonly referred
to as the priority date. Therefore, patent applications covering our new products or platform technology could have been filed by others
without our knowledge. Additionally, pending patent applications which have been published can, subject to certain limitations, be later
amended in a manner that could cover our platform technologies, our new products or the use of our new products. Third party intellectual
property right holders may also actively bring infringement claims against us. We cannot guarantee that we will be able to successfully
settle or otherwise resolve such infringement claims. If we are unable to successfully settle future claims on terms acceptable to us,
we may be required to engage in or continue costly, unpredictable and time-consuming litigation and may be prevented from or experience
substantial delays in pursuing the development of and/or marketing our new products. If we fail in any such dispute, in addition to being
forced to pay damages, we may be temporarily or permanently prohibited from commercializing our new products that are held to be infringing,
and/or we might be forced to redesign our new products to avoid infringing upon the third party's intellectual property rights.
Any of these events, even if we were ultimately to prevail, could require us to divert substantial financial and management resources
that we would otherwise be able to devote to our business.

 We may be involved in lawsuits to protect
or enforce our intellectual property, which could be expensive, time consuming, and unsuccessful.

 Competitors may infringe our intellectual property.
If we were to initiate legal proceedings against a third party to enforce a patent covering one of our new products, the defendant could
counterclaim that the patent covering our product candidate is invalid and/or unenforceable. In patent litigation in the United States,
defendant counterclaims alleging invalidity and/or unenforceability are commonplace. Grounds for a validity challenge could be an alleged
failure to meet any of several statutory requirements, including lack of novelty, obviousness, or non-enablement. Grounds for an unenforceability
assertion could be an allegation that someone connected with prosecution of the patent withheld relevant information from the United States
Patent and Trademark Office, or USPTO, or made a misleading statement, during prosecution. The validity of U.S. patents may also
be challenged in post-grant proceedings before the USPTO. The outcome following legal assertions of invalidity and unenforceability
is unpredictable.

 Derivation proceedings initiated by third parties
or brought by us may be necessary to determine the priority of inventions and/or their scope with respect to our patent or patent applications
or those of our licensors. An unfavorable outcome could require us to cease using the related technology or to attempt to license rights
to it from the prevailing party. Our business could be harmed if the prevailing party does not offer us a license on commercially reasonable
terms. Our defense of litigation or interference proceedings may fail and, even if successful, may result in substantial costs and distract
our management and other employees. In addition, the uncertainties associated with litigation could have a material adverse effect on
our ability to raise the funds necessary to continue our research programs, license necessary technology from third parties, or enter
into development partnerships that would help us bring our new products to market.

 Furthermore, because of the substantial amount
of discovery required in connection with intellectual property litigation, there is a risk that some of our confidential information could
be compromised by disclosure during this type of litigation. There could also be public announcements of the results of hearings, motions,
or other interim proceedings or developments. If securities analysts or investors perceive these results to be negative, it could have
a material adverse effect on the price of our common stock.

 We may be subject to claims challenging
the inventorship of our intellectual property.

 We may be subject to claims that former employees,
collaborators or other third parties have an interest in, or right to compensation, with respect to our current patent and patent applications,
future patents or other intellectual property as an inventor or co-inventor. For example, we may have inventorship disputes arise from
conflicting obligations of consultants or others who are involved in developing our products. Litigation may be necessary to defend against
these and other claims challenging inventorship or claiming the right to compensation. If we fail in defending any such claims, in addition
to paying monetary damages, we may lose valuable intellectual property rights, such as exclusive ownership of, or right to use, valuable
intellectual property. Such an outcome could have a material adverse effect on our business. Even if we are successful in defending against
such claims, litigation could result in substantial costs and be a distraction to management and other employees.

 We may not be able to protect our intellectual
property rights throughout the world.

 Filing, prosecuting, and defending patents on
products, as well as monitoring their infringement in all countries throughout the world would be prohibitively expensive, and our intellectual
property rights in some countries can be less extensive than those in the United States. In addition, the laws of some foreign countries
do not protect intellectual property rights to the same extent as federal and state laws in the United States.

 A substantial part of our commercial success will
depend on its ability to maintain, establish and protect its intellectual property assets, maintain trade secret protection, register
copyrights and trademarks, and operate without infringing the proprietary rights of third parties. There is a further risk that the claims
of a patent application, when filed, may change in scope during examination by the patent offices. Further, if and where a patent is granted,
there can be no guarantee that such patent will be valid or enforceable or that the patent will be granted in other jurisdictions.

 Competitors may use our technologies in jurisdictions
where we have not obtained patent protection to develop their own products and may also export otherwise infringing products to territories
where we have patent protection, but enforcement is not as strong as that in the United States. These products may compete with our
products. Future patents or other intellectual property rights may not be effective or sufficient to prevent them from competing.

 Many companies have encountered significant problems
in protecting and defending intellectual property rights in foreign jurisdictions. The legal systems of certain countries, particularly
certain developing countries, do not favor the enforcement of patents, trade secrets, and other intellectual property protection, which
could make it difficult for us to stop the marketing of competing products in violation of our proprietary rights generally. Proceedings
to enforce our patent rights in foreign jurisdictions, whether or not successful, could result in substantial costs and divert our efforts
and attention from other aspects of our business, could put our future patents at risk of being invalidated or interpreted narrowly and
our patent applications at risk of not issuing and could provoke third parties to assert claims against us. We may not prevail in any
lawsuits that we initiate, and the damages or other remedies awarded, if any, may not be commercially meaningful. Accordingly, our efforts
to monitor and enforce our intellectual property rights around the world may be inadequate to obtain a significant commercial advantage
from the intellectual property that we develop or license.

 We may become subject to claims for remuneration
or royalties for assigned service invention rights by our employees, which could result in litigation and adversely affect our business.

 A significant portion of our intellectual property
has been developed by our employees in the course of their employment for us. Under the Israeli Patent Law, 5727-1967, or the Patent
Law, inventions conceived by an employee during the scope of his or her employment with a company are regarded as "service inventions,"
which belong to the employer, absent an agreement between the employee and employer providing otherwise. The Patents Law also provides
that if there is no agreement between an employer and an employee determining whether the employee is entitled to receive consideration
for service inventions and on what terms, this will be determined by the Israeli Compensation and Royalties Committee, or the Committee,
a body constituted under the Patents Law. Case law clarifies that the right to receive consideration for "service inventions"
can be waived by the employee and that in certain circumstances, such waiver does not necessarily have to be explicit. The Committee will
examine, on a case-by-case basis, the general contractual framework between the parties, using interpretation rules of the general Israeli
contract laws. Further, the Committee has not yet determined one specific formula for calculating this remuneration, but rather uses the
criteria specified in the Patents Law. Although we generally enter into agreements with our employees pursuant to which such individuals
assign to us all rights to any inventions created during and as a result of their employment with us, we may face claims demanding remuneration
in consideration for assigned inventions. As a consequence of such claims, we could be required to pay additional remuneration or royalties
to our current and/or former employees, or be forced to litigate such monetary claims (which will not affect our proprietary rights),
which could negatively affect our business.

 Risks Related to Our Common Stock

 We are an "emerging growth company"
and our compliance with the reduced reporting and disclosure requirements applicable to "emerging growth companies" may make
our common stock less attractive to investors.

 We are an "emerging growth company,"
as defined in the Jumpstart Our Business Startups Act, or JOBS Act, and we have elected to take advantage of certain exemptions and relief
from various reporting requirements that are applicable to other public companies that are not "emerging growth companies."
These provisions include, but are not limited to: being permitted to have only two years of audited financial statements and only two
years of related management's discussion and analysis of financial condition and plan of operation disclosures; being exempt from
compliance with the auditor attestation requirements of Section 404(b) of the Sarbanes-Oxley Act; being subject to reduced disclosure
obligations regarding executive compensation in our periodic reports and proxy statements; and not being required to hold nonbinding advisory
votes on executive compensation or on any golden parachute payments not previously approved.

 In addition, while we are an "emerging growth
company," we will not be required to comply with any new financial accounting standard until such standard is generally applicable
to private companies. As a result, our financial statements may not be comparable to companies that are not "emerging growth companies"
or elect not to avail themselves of this provision.

 We may remain an "emerging growth company"
until the fiscal year-end following the fifth anniversary of the completion of our initial public offering, though we may cease to be
an "emerging growth company" earlier under certain circumstances, including if (i) we have more than $1.235 billion in annual
revenue in any fiscal year, (ii) we become a "large accelerated filer," with at least $700 million of equity securities held
by non-affiliates as of the end of the second quarter of that fiscal year, or (iii) we issue more than $1.0 billion of non-convertible
debt over a three-year period.

 The exact implications of the JOBS Act are still
subject to interpretations and guidance by the SEC and other regulatory agencies, and we cannot assure you that we will be able to take
advantage of all of the benefits of the JOBS Act. In addition, investors may find our common stock less attractive to the extent we rely
on the exemptions and relief granted by the JOBS Act. If some investors find our common stock less attractive as a result, there may be
a less active trading market for our common stock and our stock price may decline or become more volatile.

 If we fail to maintain effective internal controls
over financial reporting, the price of our common stock may be adversely affected.

 We are required to establish and maintain appropriate
internal controls over financial reporting. Failure to establish those controls, or any failure of those controls once established, could
adversely impact our public disclosures regarding our business, financial condition or results of operations. Any failure of these controls
could also prevent us from maintaining accurate accounting records and discovering accounting errors and financial fraud.

 In addition, management's assessment of
internal controls over financial reporting may identify weaknesses and conditions that need to be addressed or other matters that may
raise concerns for investors. Any actual or perceived weaknesses and conditions that need to be addressed in our internal control over
financial reporting, disclosure of management's assessment of our internal controls over financial reporting may have an adverse
impact on the price of our common stock.

 Management has identified material weaknesses regarding inadequate
accounting resources, the lack of segregation of duties and the need for a stronger internal control environment. Management of the Company
believes that these material weaknesses are due to the small size of the Company's outsourced accounting staff. The small size of
the Company's accounting outsourced staff may prevent adequate controls in the future due to the cost/benefit of such remediation.

 Compliance with changing regulation of corporate
governance and public disclosure will result in additional expenses.

 Changing laws, regulations and standards relating
to corporate governance and public disclosure, including the Sarbanes-Oxley Act of 2002 and related Commission regulations, have created
uncertainty for public companies and significantly increased the costs and risks associated with accessing the public markets and public
reporting. Our management team will need to invest significant management time and financial resources to comply with both existing and
evolving standards for public companies, which will lead to increased general and administrative costs and a diversion of management time
and attention from revenue generating activities to compliance activities.

 Our common stock may be considered a "penny
stock," and thereby be subject to additional sale and trading regulations that may make it more difficult to sell.

 Our common stock, which is currently quoted
for trading on the over-the-counter market, may be considered to be a "penny stock" if it does not qualify for one of the
exemptions from the definition of "penny stock" under Section 3a51-1 of the Securities Exchange Act for 1934, as amended (the
"Exchange Act"). Our common stock may be a "penny stock" if it meets one or more of the following conditions:
(i) the stock trades at a price less than $5.00 per share; (ii) it is not traded on a "recognized" national exchange; (iii)
it is not quoted on the NASDAQ Capital Market, or even if so, has a price less than $5.00 per share; or (iv) is issued by a company that
has been in business less than three years with net tangible assets less than $5 million.

 The principal result or effect of being designated
a "penny stock" is that securities broker-dealers participating in sales of our common stock will be subject to
the "penny stock" regulations set forth in Rules 15-2 through 15g-9 promulgated under the Exchange Act. For example, Rule
15g-2 requires broker-dealers dealing in penny stocks to provide potential investors with a document disclosing the risks of penny stocks
and to obtain a manually signed and dated written receipt of the document at least two business days before effecting any transaction
in a penny stock for the investor's account. Moreover, Rule 15g-9 requires broker-dealers in penny stocks to approve the account
of any investor for transactions in such stocks before selling any penny stock to that investor. This procedure requires the broker-dealer
to (i) obtain from the investor information concerning his or her financial situation, investment experience and investment objectives;
(ii) reasonably determine, based on that information, that transactions in penny stocks are suitable for the investor and that the investor
has sufficient knowledge and experience as to be reasonably capable of evaluating the risks of penny stock transactions; (iii) provide
the investor with a written statement setting forth the basis on which the broker-dealer made the determination in (ii) above; and (iv)
receive a signed and dated copy of such statement from the investor, confirming that it accurately reflects the investor's financial
situation, investment experience and investment objectives. Compliance with these requirements may make it more difficult and time consuming
for holders of our common stock to resell their shares to third parties or to otherwise dispose of them in the market or otherwise.

 We may be subject to securities litigation,
which is expensive and could divert management attention.

 In the past, companies that have experienced volatility
in the market price of their stock have been subject to securities class action litigation. We may be the target of this type of litigation
in the future. Litigation of this type could result in substantial costs and diversion of management's attention and resources,
which could seriously hurt our business. Any adverse determination in litigation could also subject us to significant liabilities.

 If securities or industry analysts do not
publish or cease publishing research or reports about us, our business or our market, or if they adversely change their recommendations
or publish negative reports regarding our business or our shares, our share price and trading volume could decline.

 The trading market for our common stock will be
influenced by the research and reports that industry or securities analysts may publish about us, our business, our market or our competitors.
We do not have any control over these analysts and we cannot provide any assurance that analysts will cover us or provide favorable coverage.
If any of the analysts who may cover us adversely change their recommendation regarding our shares, or provide more favorable relative
recommendations about our competitors, our share price would likely decline. If any analyst who may cover us were to cease coverage of
our company or fail to regularly publish reports on us, we could lose visibility in the financial markets, which in turn could cause our
share price or trading volume to decline.

 We have no operating experience as a publicly
traded company in the United States.

 We have no operating experience as a publicly
traded company in the U.S. Although at least one individual who now constitutes our management team has experience managing a publicly-traded
company, there is no assurance that the past experience of our management team will be sufficient to operate our company as a publicly
traded company in the United States, including timely compliance with the disclosure requirements of the SEC. In addition,
our management team may not be able to successfully or efficiently manage our company as a U.S. public reporting company that is
subject to regulatory oversight and reporting obligations.

 Raising additional capital will cause dilution
to our existing stockholders and may affect the rights of existing stockholders.

 We may seek additional capital through a combination
of private and public equity offerings, debt financings and collaborations and strategic and licensing arrangements. To the extent that
we raise additional capital through the issuance of equity or convertible debt securities, stockholders' ownership interest will
be diluted, and the terms may include liquidation or other preferences that adversely affect your rights as a holder of our common stock.

 Sales of a substantial number of shares
of our common stock in the public market by our existing stockholders could cause our share price to fall.

 Sales of a substantial number of shares of our
common stock in the public market, or the perception that these sales might occur, could depress the market price of our common stock
and could impair our ability to raise capital through the sale of additional equity securities. We are unable to predict the effect that
sales may have on the prevailing market price of our common stock.

 We have never paid, and we currently do
not intend to pay dividends.

 We have never declared or paid any cash dividends
on our common stock. We currently intend to retain any future earnings to finance operations and to expand our business and, therefore,
do not expect to pay any cash dividends in the foreseeable future. As a result, capital appreciation, if any, of our common stock will
be investors' sole source of gain for the foreseeable future. In addition, Israeli law may limit our declaration or payment of dividends
and may subject our dividends to Israeli withholding taxes.

 Risks Related to Our Location and Operations
in Israel

 We are exposed to fluctuations in currency
exchange rates.

 A major portion of our business is conducted,
and a material portion of our operating expenses is incurred, outside the United States, mainly in New Israeli Shekels ("NIS"). Therefore,
we are exposed to currency exchange fluctuations in other currencies, particularly in NIS and the risks related thereto. Our primary expenses
paid in NIS are employee salaries, fees for consultants and subcontractors and lease payments on our Israeli facilities. As a result,
we are affected by foreign currency exchange fluctuations through both translation risk and transaction risk. Thus, we are exposed to
the risks that: (a) the NIS may appreciate relative to the dollar; (b) the NIS devalue relative to the dollar; (c) the
inflation rate in Israel may exceed the rate of devaluation of the NIS; or (d) the timing of such devaluation may lag behind inflation
in Israel. In any such event, the dollar cost of our operations in Israel would increase and our dollar-denominated results of operations
would be adversely affected. Our operations also could be adversely affected if we are unable to effectively hedge against currency fluctuations
in the future.

 Our headquarters, research and development
and other significant operations are located in Israel, and, therefore, our results may be adversely affected by political, economic and
military instability in Israel.

 We have offices in Tel Aviv, Israel where our
primary operations, research and development, and certain other finance activities are based. In addition, all of our officers and directors
are residents of Israel. Accordingly, political, economic and military conditions in Israel and the surrounding region may directly affect
our business and operations. Since the establishment of the State of Israel in 1948, a number of armed conflicts have taken place between
Israel and its neighboring countries and terrorist organizations, including Hamas (an Islamist militia and political group in the Gaza
strip) and Hezbollah (an Islamist militia and political group based in Lebanon).

 In October 2023, Hamas
terrorists infiltrated Israel's southern border from the Gaza Strip and conducted a series of attacks on civilian and military targets.
Hamas also launched extensive rocket attacks on Israeli population and industrial centers located along Israel's border with the
Gaza Strip and in other areas within the State of Israel. These attacks resulted in extensive deaths, injuries and kidnapping of civilians
and soldiers. Following the attack, Israel's security cabinet declared war against Hamas and a military campaign against these terrorist
organizations commenced in parallel to their continued rocket and terror attacks.

 In connection with the
Israeli security cabinet's declaration of war against Hamas and possible hostilities with other organizations, several hundred thousand
Israeli military reservists were drafted to perform immediate military service, including five full time employees in Israel of ours.
Although many of such military reservists have since been released, including all our employees, they may be called up for additional
reserve duty, depending on developments in the war in Gaza and along Israel's other borders. Military service call ups that result
in absences of personnel from us for an extended period of time may materially and adversely affect our business, prospects, financial
condition and results of operations. As of March 12, 2025, we have two senior management
positions, who we engage in part-time capacities via consulting agreements. In addition, we have four
(4) engineers working for us as part-time consultants. All of these individuals are located in Israel.

 Since the commencement
of these events, there have been continued hostilities along Israel's northern border with the Hezbollah terror organization), with
the Houthis in Yemen and on other fronts with various extremist groups in the region, such as various rebel militia groups in Syria and
Iraq. In October 2024, Israel began limited ground operations against Hezbollah in Lebanon, and in November 2024, a ceasefire was brokered
between Israel and Hezbollah. It is possible that hostilities with Iran, Hezbollah, the Houthis and Syria will escalate, and that other
terrorist organizations, including Palestinian military organizations in the West Bank, will join the hostilities. In addition, Iran recently
launched direct attacks on Israel involving hundreds of drones and missiles, has threatened to continue to attack Israel, and is widely
believed to be developing nuclear weapons. Iran is also believed to have a strong influence among extremist groups in the region, such
as Hamas in Gaza, Hezbollah in Lebanon, the Houthis in Yemen and various rebel militia groups in Syria and Iraq. These situations may
potentially escalate in the future to more violent events which may affect Israel and us. Any hostilities, armed conflicts, terrorist
activities involving Israel or the interruption or curtailment of trade between Israel and its trading partners, or any political instability
in the region could adversely affect business conditions and our results of operations and could make it more difficult for us to raise
capital and could adversely affect the market price of our shares. An escalation of tensions or violence might result in a significant
downturn in the economic or financial condition of Israel, which could have a material adverse effect on our operations in Israel and
our business. Parties with whom we do business have sometimes declined to travel to Israel during periods of heightened unrest or tension,
forcing us to make alternative arrangements when necessary in order to meet our business partners face to face. In addition, the political
and security situation in Israel may result in parties with whom we have agreements involving performance in Israel claiming that they
are not obligated to perform their commitments under those agreements pursuant to force majeure provisions in such agreements.

 Since the war broke out
on October 7, 2023, our operations have not been adversely affected by this situation, and we have not experienced disruptions to
our business operations. As such, our product and business development activities remain on track. However, the intensity and duration
of the security situation in Israel is difficult to predict at this stage, as are such war's economic implications on our business
and operations and on Israel's economy in general. If the ceasefire declared collapses or a new war commences or hostilities expand
to other fronts, our operations may be adversely affected.

 Our commercial insurance
does not cover losses that may occur as a result of events associated with war and terrorism. Although the Israeli government currently
covers the reinstatement value of direct damages that are caused by terrorist attacks or acts of war, we cannot assure you that this government
coverage will be maintained or that it will sufficiently cover our potential damages. Any losses or damages incurred by us could have
a material adverse effect on our business. Any armed conflicts or political instability in the region would likely negatively affect business
conditions and could harm our results of operations.

 Finally, political conditions within Israel may
affect our operations. Israel has held five general elections between 2019 and 2022, and prior to October 2023, the Israeli government
pursued extensive changes to Israel's judicial system, which sparked extensive political debate and unrest. Actual or perceived political instability in Israel or any negative changes in the political environment,
may individually or in the aggregate adversely affect the Israeli economy and, in turn, our business, financial condition, results of
operations and growth prospects.

 Our operations
may be disrupted as a result of the obligation of management or key personnel to perform military service.

 All of our officers and employees reside in Israel
and many may be required to perform annual military reserve duty. Currently, all male adult citizens and permanent residents of Israel
under the age of 40 (or older, depending on their position with the Israeli Defense Forces reserves), unless exempt, are obligated to
perform military reserve duty annually and are subject to being called to active duty at any time under emergency circumstances. Our operations
could be disrupted by the absence for a significant period of one or more of our key officers and employees due to military service. Any
such disruption could have a material adverse effect on our business, results of operations and financial condition.

 ITEM 1B. UNRESOLVED
STAFF COMMENTS

 None.

 ITEM 1C. CYBERSECURITY

 Risk management
and strategy

 We
are in the process of developing a cybersecurity risk management program, consisting of cybersecurity policies, procedures, compliance
and awareness programs to mitigate risk and to ensure compliance with security, availability and confidentiality trust principles. Following
the completion of the development of our cybersecurity risk management program, the cybersecurity process will be integrated into our
overall risk management system and process, and, initially, will be solely internally managed. Management is responsible for identifying
risks that threaten achievement of the control activities stated in the management's description of the services organizations systems.
Management has started to implement a process for identifying relevant risks that could affect the organization's ability to provide
secure and reliable service to its users. The risk assessment will occur annually, or as business needs change, and covers identification
of risks that could act against the company's objectives as well as specific risks related to a compromise to the security of data.
 Most of the information generated and collected by us is stored and maintained by third-party vendors and service providers. We believe
that each of these providers has its own cybersecurity protocols to which our management believes to be adequate for protecting our files
in their possession. For more information about these risks, please see "Item 1.A – Risk Factors – Risks Related to
Our Business and Industry – Significant disruptions of our information technology systems or breaches of our data security could
adversely affect our business." in this annual report.

 Governance

 Our Board of Directors considers
cybersecurity risk as part of its risk oversight function and oversees cybersecurity risk strategy and governance and other information
technology risks. Our Chief Executive Officer and Chief Financial Officer are responsible
for assessing and managing cybersecurity risk, and providing briefings regarding the assessment and management of such risk to the Board
of Directors. Although our senior management do not have direct cybersecurity expertise obtained through certifications, their
experience managing the Company, which includes consulting and coordinating as necessary with a third party information technology expert
referred to below, enables them to effectively assess and manage material risks from cybersecurity threats.

 The Company retained an information
technology expert third party company to assist in managing relevant risks. In particular, the Company outsources its information technology
function and monitoring to a third party provider whereby it benefits from a professionally managed network monitoring, management, maintenance,
detection and response system and a 24/7 security operations center with both onsite and remote support services. Any cybersecurity incident
would be reported to the Company promptly by our third party consultant and material and potentially material incidents would be assessed
by management and the Board of Directors for remediation and future prevention and detection.

 The Company, at least annually, updates its policies
or procedures that could help mitigate cybersecurity risks. Notwithstanding the extensive approach we take to cybersecurity, we may not
be successful in preventing or mitigating a cybersecurity incident that could have a material adverse effect on us. The Company has incorporated
cybersecurity coverage in its insurance policies; however, there is no assurance that the insurance the Company maintains will cover all
cybersecurity breaches or that policy limits will be sufficient to cover all related losses.

 As of the date of this
report, we are not aware of any material risks from cybersecurity threats that have materially affected or are reasonably likely to materially
affect us, including our business strategy, results of operations or financial condition.

 ITEM 2. PROPERTIES

 The Company neither rents nor owns any properties.
The Company currently utilizes (i) the office space of certain shareholders in Tel Aviv, Israel and (ii) a small laboratory for research
and development purposes, owned by our CEO in Kadima, Israel 6095216, each at no cost. Given the limited need of the Company, management
believes that the office space and laboratory are more than suitable and adequate for the Company's needs. In January 2025, we started
to rent an office, lab and assembly and integration area in an innovation and startup hub located in "The Rupin Technological Campus"
about 40km north of Tel Aviv. The monthly rental fee is 4,000 NIS (approx. $1,100). The Company currently has no policy with respect to
investments or interests in real estate, real estate mortgages or securities of, or interests in, persons primarily engaged in real estate
activities.

 ITEM 3. LEGAL PROCEEDINGS

 We are not a party to any legal proceedings, nor
are we aware of any threatened litigation.

 ITEM 4. MINE SAFETY DISCLOSURES

 ITEM 5. MARKET FOR REGISTRANT'S COMMON
EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

 Market Information

 Our common stock, par value $0.0001 per share,
is listed for quotation on the OTC Markets under the ticker symbol "CHEV."

 Holders

 As of March
12, 2025, we had 141 shareholders of record. The actual number of stockholders is greater than this number of record holders and
includes stockholders who are beneficial owners but whose shares are held in street name by brokers and other nominees.

 Dividend Policy

 We have never declared or paid cash dividends
on our common stock. We intend to retain our future earnings, if any, in order to reinvest in the development and growth of our business
and, therefore, do not intend to pay dividends on our common stock for the foreseeable future. Any future determination to pay dividends
will be at the discretion of our Board of Directors and will depend on our financial condition, results of operations, capital requirements,
and such other factors as our Board of Directors deems relevant.

 Securities Authorized for Issuance under Equity
Compensation Plans

 Information about our equity compensation plans
is incorporated herein by reference to "Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder
Matters", of this Annual Report on Form 10-K.

 Recent Sales of Unregistered Securities

 None.

 ITEM 6. [Reserved]

 As a "smaller reporting company" as
defined by Item 10 of Regulation S-K, we are not required to provide this information.

 ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS
OF FINANCIAL CONDITIONS AND RESULT OF OPERATIONS

 You should read the following discussion along
with our financial statements and the related notes included elsewhere in this Annual Report on Form 10-K. The following discussion contains
forward-looking statements that are subject to risks, uncertainties and assumptions, including those discussed under "Risk Factors."
Our actual results, performance and achievements may differ materially from those expressed in, or implied by, these forward-looking statements.

 Overview

 Charging Robotics is engaged in the development,
production and installation of wireless charging systems for various applications. The current focus of the company is wireless charging
systems for EVs in robotic parking systems. The Company believes that this technology addresses a significant need, as cable-based charging
systems are not feasible in these types of parking systems

 Our wholly-owned subsidiary, Charging Robotics Ltd.,
was formed in February 2021, as an Israeli corporation, with the main goal of developing an innovative wireless EV charging technology.
At the heart of the technology is a wireless power transfer module that uses resonance induction coils to transfer electricity wirelessly.
This module can be used for various products such as robotic and stationary platforms. The robotic platform will include a component which
is small enough to fit under the vehicle, and which will automatically position itself for maximum-efficiency charging, and upon charging
completion will automatically return to its docking station or to charge the next vehicle.

 Recent Developments

 Our current product,
which we are pilot testing with an APS supplier in Israel, is a system that wirelessly charges EVs in APSs. Upon arrival at the APS,
the driver parks the EV on a plate used by the APS to transport the EV to the final parking location. The EV remains on the plate until
it is retrieved by the APS and the driver enters the EV departs. When a driver parks an EV on these charging plates, they connect a regular
charging cable to a socket installed on the plate, at which point the plate moves through the APS via conveyors and elevators to the parking
location. Our system is installed in two parts. The electricity receiving component is installed on the plate and consists of a receiving
coil and supporting electronics and a socket where the driver connects a cable to the charging socket of the EV. The system's transmitting
component is installed in the APS facility and consists of a transmitting coil and the supporting electronics. As the driver parks the
EV and connects the cable from the plate to the EV, he initiates that charging using our mobile application. Once initiated, the system
goes into standby mode. Upon the plate arriving at its final parking location, charging of the EV begins. When the plate and EV are in
the final parking position, the transmitting coil and the receiving coil are in proximity and by way of electromagnetic induction, electricity
passes from the stationary part (transmitting) of the system to the moving (receiving) part of the system. This enables the charging of
EVs in places where drivers can not enter and manually connect a plug.

 Although we have decided
to currently focus on the solution for APSs, longer term future products will include the robotic solutions on which the Company was founded.
We have succeeded in developing a tethered robotic solution. This robot was intended to charge an EV of a disabled driver and offer an
automatic method for wireless charging of EVs. This solution will offer a big benefit for disabled drivers who have difficulty using a
regular plug-and-cable-based charger. For these drivers, it is merely impossible to exit the EV, go to the charger, take the cable and
connect the plug to the EV. Using our solution, charging will be performed automatically using the tethered robot. As the driver parks
the EV, that robot will recognize the EV and will automatically navigate under the EV and charge it wirelessly. For this we have developed
a patent-pending technology to navigate to the EV using data obtained by lidar (laser-based) sensors viewing only the EV's wheels.

 The Company concluded
a pilot testing project of its product with an Israeli company that installs and operates APSs. This pilot project was partially funded
by the Israeli Innovation Authority. Based on this pilot test, the Company has begun developing its next generation product with new features
and fixes that will make it more suitable for mass production and sales. This next generation of the Company's product is expected
to be ready for commercialization in January 2025. The Company's expected timeframe to receive regulatory approval for this product
from the Israel Standardization Institute has been slightly delayed, with the new expected timing for approval to occur by April 2025.

 The purchase order received from an APS provider
in Israel for installation of multiple systems in June 2025 was delayed and the systems are now expected to be installed towards the end
of 2025. We are also in discussions with three other APS providers in Israel. The combined forecast from these customers and potential
customers is installation of approximately thirty systems by the end of 2024. We see this growth as indicative of a favorable response
from the market to our systems.

 In order to prepare to meet this increased market
demand, we are in the process of establishing subcontractor-based production capabilities, working on increasing our work force and sourcing
office and R&D spaces. In January 2025, we started to rent an office, lab, assembly and integration area in an innovation and startup
hub located in "The Rupin Technological Campus" about 40km north of Tel Aviv.

 On April 23, 2024, the Company received notice
from FINRA that the Name Change and the Reverse Stock Split was announced on FINRA's daily list and would take effect at market
open on the Market Effective Date. Accordingly, the FINRA corporate action to effect the Name Change and the Reverse Stock Split is now
completed. Consequently, all share numbers, share prices, and exercise prices have been retroactively adjusted in this management's
discussion and analysis of financial condition and results of operations.

 In December 2024, the Company sold a total of 412,123 newly issued
shares of common stock to a total of seven investors for a total of $410,000.

 On January 15, 2025, the Company sold a total of 30,303 newly issued
shares of common stock to a total of seven investors for a total of $50,000.

 Results of Operations For the Years Ended December 31, 2024 and
December 31, 2023

 Operating Expenses and Revenues

 Our current operating expenses consist of two
components — research and development costs, net, and general and administrative
costs. We have not generated revenues for the years
ended December 31, 2024, and December 31, 2023, respectively.

 Research and development costs, net

 Research and development costs, net for the year ended December 31,
2024, amounted to $319 thousand, compared to $329 thousand for the year ended December 31, 2023. The decrease is mainly due to a decrease
in subcontractor costs, which amounted to $251 thousand during the year ended December 31, 2024, compared to $258 thousand during the
year ended December 31, 2023. The decrease in research and development expenses was offset in part by a decrease in the grant received
from by the Israeli Innovation Authority, which amounted to $58 thousand during the year ended December 31, 2024, compared to $77 thousand
during the year ended December 31, 2023, and an increase in raw materials, which amounted to $39 thousand during the year ended December
31, 2024, compared to $2 thousand in the ended December 31, 2023. The increase in raw materials is due to the development of the pilot
project.

 General and administrative costs

 General and administrative costs for the year
ended December 31, 2024, amounted to $458 thousand, compared to $437 thousand for the year ended December 31, 2023. The increase is due
to increased business and other operational activity in the Company, specifically public company expenses.

 Liquidity and Capital Resources

 As of December 31, 2024 and December 31, 2023,
the Company's cash balance was $175 thousand and $8 thousand, respectively.

 As of December 31, 2024 and December 31, 2023,
the Company's total assets were $332 thousand and $223 thousand, respectively.

 As of December 31, 2024, the Company had total liabilities of $945
thousand that consisted of $328 thousand in accounts payable and other current liabilities, $172 thousand in payables to related parties,
$32 thousand in other non-current liabilities and $413 thousand in short term loans.

 As of December 31, 2023, the Company had total
liabilities of $397 thousand that consisted of $220 thousand in accounts payable and other current liabilities, $98 thousand in payables
to related parties, $49 thousand in other non-current liabilities and $30 thousand in short term loans.

 As of December 31, 2024 and 2023, the Company had a negative working
capital of $654 thousand and $297 thousand, respectively.

 The Company's operating budget needs to include the planned costs
to operate its business, including amounts required to fund the working capital and capital expenditure. The Company's future capital
requirements and the adequacy of its available funds will depend on many factors, including the Company's ability to successfully
commercialize its products and services, competing technological and market developments, and the need to enter into collaborations with
other companies or acquire other companies or technologies to enhance or complement its product and service offerings. The Company may
be unable to raise sufficient additional capital when it needs it or raise capital on favorable terms. Future financing may require the
Company to pledge certain assets and enter into covenants that could restrict certain business activities or its ability to incur further
indebtedness and may contain other terms that are not favorable to its shareholders or to the Company. If the Company is unable to obtain
adequate funds on reasonable terms, it may be required to significantly curtail or discontinue operations or obtain funds by entering
into financing agreements on unattractive terms.

 Working Capital and Cash Flows (in thousands
of U.S. Dollars)

 Working Capital

 2024

 2023

 Current Assets

 $

 $

 Current Liabilities

 Working Capital (deficit)

 $
 (654
)

 $
 (297
)

 Cash Flows

 2024

 2023

 Cash flows used in operating activities

 $
 (610
)

 $
 (643
)

 Cash flows used in investing activities

 -

 Cash flows from financing activities

 Net increase (decrease) in cash during the year

 (19
)

 Cash Flows from Operating Activities

 During the year ended December 31, 2024, we had negative cash flow
from operations of $610 thousand compared to a negative cashflow of $643 thousand for the year ended December 31, 2023, which resulted
mainly from the net loss for the year.

 Cash Flows from Investing Activities

 During the year ended December 31, 2024, we had
nil cashflow from investing activities, compared to a positive cashflow of $3 thousand for the year ended December 31, 2023.

 Cash Flows from Financing Activities

 During
the year ended December 31, 2024, we had a positive cash flow from financing activities of $777 thousand, compared to a positive cashflow
of $621 thousand for the year ended December 31, 2023. Cash flows in 2024 were primarily from an issuance of common stock in the amount
of $410 thousand and receipt of short-term loans in the amount of $367 thousand. Cash flows in 2023 were primarily from a private placement
of common stock in the amount of $501 thousand and the exercise
of stock options in the amount of $91 thousand.

 Critical Accounting Estimates

 The preparation of financial statements in conformity with GAAP requires
management to make estimates and assumptions that affect reported amounts and disclosures. It is reasonably possible that actual experience
could differ from the estimates and assumptions utilized which could have a material impact on the financial statements. The following
is a summary of our significant accounting estimates, and critical issues that impact them:

 Accounting for stock-based compensation

 We grant equity-based awards under share-based
compensation plans. We estimate the fair value of share-based payment awards using the Black-Scholes option valuation model. The Black-Scholes
option valuation model requires the input of subjective assumptions, including price volatility of the underlying stock, risk-free interest
rate, dividend yield, and expected life of the option. Because the Company did not have a trading history of its common stock, the expected
volatility was derived from the average stock volatilities of similar public companies within the Company's industry that we considered
to be comparable to our business over a period equivalent to the expected term of the stock option and warrants granted. Changes in assumptions
used under the Black-Scholes option valuation model could materially affect our net loss and net loss per share.

 Off-Balance Sheet Arrangements

 We have not entered into any off-balance sheet
arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition,
revenues or expenses, results of operations, liquidity, capital expenditures or capital resources and would be considered material to
investors.

 Default on Notes

 There are currently no notes in default.

 Other Contractual Obligations

 As of December 31, 2024, we did
not have any contractual obligations.

 ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES
ABOUT MARKET RISK.

 As a "smaller reporting company" as
defined by Item 10 of Regulation S-K, we are not required to provide this information.

 ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY
DATA

 CONSOLIDATED FINANCIAL STATEMENTS

 AS OF DECEMBER 31, 2024

 U.S. DOLLARS IN THOUSANDS

 Page

 Report of Independent Registered Public Accounting Firm (PCAOB ID 1197)

 Consolidated Balance Sheets

 Consolidated Statements of Comprehensive Loss

 Consolidated Statements of Stockholders' Deficit

 Consolidated Statements of Cash Flows

 Notes to Consolidated Financial Statements

 F- 1

 REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM

 To the stockholders and the Board of Directors of Charging Robotics
Inc.

 Opinion on the Financial Statements

 We have audited the accompanying consolidated balance sheets of Charging
Robotics Inc. and subsidiaries (the "Company") as of December 31, 2024 and 2023, the related consolidated statements of comprehensive
loss, changes in stockholders' deficit, and cash flows, for each of the two years in the period ended December 31, 2024, and the related
notes (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in
all material respects, the financial position of the Company as of December 31, 2024 and 2023, and the results of its operations and its
cash flows for each of the two years in the period ended December 31, 2024, in conformity with accounting principles generally accepted
in the United States of America.

 Going Concern

 The accompanying financial statements have been prepared assuming that
the Company will continue as a going concern. As discussed in Note 1 to the financial statements, the Company's substantial operating
losses and lack of sufficient resources raise substantial doubt about its ability to continue as a going concern. Management's plans
concerning these matters are also described in Note 1 to the financial statements. The financial statements do not include any adjustments
that might result from the outcome of these uncertainties.

 Basis for Opinion

 These financial statements are the responsibility of the Company's
management. Our responsibility is to express an opinion on the Company's financial statements based on our audits. We are a public
accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent
with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities
and Exchange Commission and the PCAOB.

 We conducted our audits in accordance with the standards of the PCAOB.
Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free
of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit
of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control
over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control
over financial reporting. Accordingly, we express no such opinion.

 Our audits included performing procedures to assess the risks of material
misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures
included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included
evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation
of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

 /s/ Brightman Almagor Zohar & Co.

 Brightman Almagor Zohar & Co.

Certified Public Accountants

A Firm in the Deloitte Global Network

 Tel Aviv, Israel

 We have served as the Company's auditor since 2025.

 F- 2

 CONSOLIDATED BALANCE SHEETS

 U.S. dollars in thousands, except share and
per share data

 2024

 2023

 ASSETS

 Current assets:

 Cash

 $

 $

 Other accounts receivable

 Loan to an affiliate (Note 3b)

 -

 Total current assets

 Non-current assets:

 Investment in an affiliate (Note 3c)

 Loan to an affiliate (Note 3b)

 -

 Total non-current assets

 TOTAL ASSETS

 $

 $

 LIABILITIES & STOCKHOLDERS' DEFICIT

 Current liabilities:

 Accounts payable

 $

 $

 Other current liabilities

 Short term loans

 Payables to related parties (Note 4)

 Total current liabilities

 Non-current liabilities:

 Other non-current liabilities

 $

 $

 Total liabilities

 $

 $

 Stockholders' deficit (Note 5):

 Preferred shares, par value $ 0.0001, 10,000,000 shares authorized, 0 shares issued and outstanding

 -

 -

 Common stock, par value $ 0.0001, 2,990,000,000 shares authorized, 9,564,351 shares issued and outstanding as of December 31, 2024 and 9,152,228 shares issued and outstanding as of December 31, 2023

 Additional paid-in capital

 2,324

 1,918

 Accumulated other comprehensive loss

 ( 30
)

 ( 27
)

 Accumulated deficit

 ( 2,908
)

 ( 2,066
)

 Total stockholders' deficit

 ( 613
)

 ( 174
)

 TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT

 $

 $

these consolidated financial statements.

 F- 3

 CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

 U.S. dollars in thousands, except share
and per share data

 Year ended December 31,

 2024

 2023

 Research and development costs, net

 $

 $

 General and administrative costs

 Total operating expenses

 Operating loss

 $
 ( 777
)

 $
 ( 766
)

 Financial expenses

 ( 29
)

 ( 11
)

 Equity in losses from investment in affiliate

 ( 36
)

 ( 27
)

 $
 ( 842
)

 $
 ( 804
)

 Other comprehensive loss:

 Foreign currency translation adjustments

 ( 3
)

 ( 15
)

 Total comprehensive loss

 $
 ( 845
)

 $
 ( 819
)

 Basic and diluted loss per common stock

 $
 ( 0.09
)

 $
 ( 0.10
)

 Weighted average common stock outstanding

 9,157,398

 7,807,370

these consolidated financial statements.

 F- 4

 CONSOLIDATED STATEMENTS OF STOCKHOLDERS'
DEFICIT

2023

 U.S. dollars in thousands, except share and
per share data

 Common stock

 Additional
 Paid in

 other
 comprehensive

 Total
 Shareholders'

 Number

 Amount

 Capital

 loss

 Deficit

 Equity

 Balance as of January 1, 2023

 4,311,309

 $

 $

 $
 ( 12
)

 $
 ( 1,262
)

 $
 ( 442
)

 Exercise of stock options

 628,045

 (*
)

 -

 -

 Stock-based compensation

 -

 -

 -

 -

 Issuance of common stock upon conversion of loan

 1,206,834

 (*
)

 -

 -

 Effect of reverse recapitalization

 2,096,040

 (*
)

 ( 24
)

 -

 -

 ( 24
)

 Issuance of common stock in a private placement offering

 910,000

 (*
)

 -

 -

 Total comprehensive loss

 -

 -

 -

 ( 15
)

 ( 804
)

 ( 819
)

 Balance as of December 31, 2023

 9,152,228

 $

 $
 1,918

 $
 ( 27
)

 $
 ( 2,066
)

 $
 ( 174
)

 Common stock

 Additional
 Paid in

 other
 comprehensive

 Total
 Shareholders'

 Number (**)

 Amount

 capital

 loss

 Deficit

 Deficit

 Balance as of January 1, 2024

 9,152,228

 $

 $
 1,918

 $
 ( 27
)

 ( 2,066
)

 $
 ( 174
)

 Stock-based compensation

 -

 -

 ( 4
)

 -

 -

 ( 4
)

 Issuance of common stock in a private placement offering

 412,123

 (*

)

 -

 -

 Total comprehensive loss

 -

 -

 -

 ( 3
)

 ( 842
)

 ( 845
)

 Balance as of December 31, 2024

 9,564,351

 $

 $
 2,324

 $
 ( 30
)

 ( 2,908
)

 $
 ( 613
)

 (*)
 Less than $1 thousand.

 (**)
 On August 28, 2023, the Company amended and restated its Certificate of Incorporation to effect a 1 for 150 Reverse Stock Split of its outstanding shares of common stock effective April 24, 2024. Consequently, all share numbers, share prices, and exercise prices have been retroactively adjusted in these consolidated financial statements for all periods presented.

these consolidated financial statements.

 F- 5

 CONSOLIDATED STATEMENTS OF CASH FLOWS

 For the Years Ended December 31, 2024 and 2023

 U.S. dollars in thousands

 For the year ended

 2024

 2023

 CASH FLOWS FROM OPERATING ACTIVITIES:

 $
 ( 842
)

 $
 ( 804
)

 Adjustments to reconcile net loss to net cash used in operating activities:

 Stock-based compensation expense (income)

 ( 5
)

 Equity in losses from investment in affiliate

 Non-cash interest expenses

 ( 4
)

 Changes in operating assets and liabilities:

 Decrease in other accounts receivable

 Increase in payables to related parties

 Decrease in other non-current liabilities

 ( 17
)

 -

 Decrease in accounts payable

 ( 23
)

 ( 69
)

 Increase in other current liabilities

 Net cash used in operating activities

 ( 610
)

 ( 644
)

 CASH FLOWS FROM INVESTING ACTIVITIES:

 Cash received in the reverse recapitalization

 -

 Net cash provided by investing activities

 -

 CASH FLOWS FROM FINANCING ACTIVITIES:

 Proceeds from issuance of common stock in a private placement offering

 Proceeds from exercise of stock options

 -

 Proceeds from short term loans

 Net cash provided by financing activities

 Net increase (decrease) in cash

 ( 19
)

 Cash at beginning of year

 Cash at end of year

 $

 $

 NON-CASH FINANCING AND INVESTING ACTIVITIES

 Effect of reverse recapitalization:

 Increase in accounts payable

 -

 Decrease in payables to related parties

 -

 Decrease in additional paid in capital

 -

 Issuance of common stock upon conversion of loan

 $
 -

 $

these consolidated financial statements.

 F- 6

2023

 NOTE 1 – GENERAL

 A.
 Charging Robotics Inc. (the "Company") was incorporated in the State of Delaware on March
25, 2008. On April 23, 2024, the Company changed its name to Charging Robotics Inc. from Fuel Doctor Holdings, Inc.

 B.
 On March 28, 2023, the Company entered into a Securities Exchange Agreement
(the "Acquisition Agreement") with the stockholders of Charging Robotics Ltd. ("CR Ltd."). Pursuant to the Acquisition
Agreement, at the closing, which occurred on April 7, 2023 (the "Closing"), the Company acquired 100 % of the issued and outstanding
stock of CR Ltd. (the "Acquisition"), making CR Ltd. a wholly owned subsidiary of the Company, in exchange for the issuance
of a total of 6,146,188 newly-issued shares of common stock to the former shareholders of CR Ltd.

 The transactions arising from the Acquisition
Agreement were accounted for as a reverse recapitalization. CR Ltd. was determined to be the "accounting acquirer" in the
reverse recapitalization because (1) the former shareholders of CR Ltd., as a group, received the largest ownership interest in the Company,
based upon the 6,146,188 shares of common stock issued at the Closing, and the 6,150,000 warrants exercisable at par, and (2) most significantly,
the fact that the Acquisition Agreement expressly provided that a majority of the Company's board of directors will be appointed
by the former shareholders of CR Ltd. The Company's financial statements represent a continuation of the financial statements of CR Ltd.
with the acquisition of Fuel Doctor Holding Inc.'s net assets.

 CR Ltd. was formed in February 2021,
as an Israeli corporation, with the main goal of developing an innovative wireless electric vehicles (EV) charging technology. At the
heart of the technology is a wireless power transfer module that uses resonance coils to transfer electricity wirelessly. This module
can be used for various products such as robotic and stationary platforms. The robotic platform includes a component which is small enough
to fit under the vehicle, and which automatically positions itself for maximum-efficiency charging, and upon charging completion automatically
returns to its docking station. CR Israel also developed a Wireless EV Charging System for automatic parking lots based on our wireless
electricity transfer module.

 C.
 On April 6, 2023, the Company issued a total of 910,000 newly issued shares of common stock in a
private placement offering for total proceeds of $ 501.

 D.
 On November 22, 2023, the Company announced that CR Ltd. received approval for funding from the Israel Innovation Authority (the "IIA") for a pilot project to include installing and demonstrating its solution for wireless charging of EVs in automated parking systems ("APS"). The total approved budget for this project was approximately $ 445 thousand, of which the IIA would finance 50 %. The Company is now engaged in the pilot project to implement the solution in an APS in Tel Aviv. As of December 31, 2024, CR Israel received a total of $ 135 thousand from the IIA.

 F- 7

2023

 NOTE 1 – GENERAL (Continued)

 E.

 On August 28, 2023, the Company filed an amended and restated certificate of incorporation (the "Amended and Restated Certificate of Incorporation"), to (i) change its name to Charging Robotics Inc. (the "Name Change"); and (ii) effect a one-for-one hundred fifty reverse stock split (the "Reverse Stock Split") of its outstanding shares of common stock. Consequently, all share numbers, share prices, and exercise prices have been retroactively adjusted in these consolidated financial statements for all periods presented.

 On August 28, 2023, the Company submitted
an Issuer Company-Related Action Notification Form to the Financial Industry Regulatory Authority, Inc. ("FINRA") regarding
the Name Change and Reverse Stock Split.

 On April 23, 2024, the Company received
notice from FINRA that the Name Change and the Reverse Stock Split was announced on FINRA's daily list and would take effect at
market open on the Market Effective Date. Accordingly, the FINRA corporate action to effect the Name Change and the Reverse Stock Split
was completed on April 23, 2024.

 F.
 The consolidated financial statements have been prepared on a going concern basis which assumes the Company
will be able to realize its assets and meet its obligations in the normal course of business for the foreseeable future.

 Since its inception, the Company has devoted substantially all its
efforts to research and development. The Company has incurred operating losses since its inception and expects to continue to incur operating
losses for the near-term. As of December 31, 2024, the Company had an accumulated deficit of approximately $ 2,908. The extent of
the Company's future operating losses and the timing of becoming profitable are uncertain. Management expects the Company to continue
to generate substantial operating losses and to continue to fund its operations primarily through utilization of its current financial
resources and through additional raises of capital.

 Such conditions raise substantial doubts
about the Company's ability to continue as a going concern. Management's plan includes raising funds from outside potential
investors. However, there is no assurance such funding will be available to the Company or that it will be obtained on terms favorable
to the Company or will provide the Company with sufficient funds to meet its objectives. These consolidated financial statements do not
include any adjustments relating to the recoverability and classification of assets, carrying amounts or the amount and classification
of liabilities that may be required should the Company be unable to continue as a going concern.

 F- 8

2023

 NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 a. Basis of presentation of the financial statements:

 The Company's consolidated financial
statements have been prepared in accordance with the United States generally accepted accounting principles (U.S. GAAP) as set forth in
the Financial Accounting Standards Board (the "FASB") Accounting Standards Codification (the "ASC").

 b. Use of estimates, assumptions and judgements:

 The preparation of financial statements
in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported in the
consolidated financial statements and accompanying notes. The Company's management believes that the estimates, judgment and assumptions
used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect
the reported amounts of assets and liabilities at the dates of the consolidated financial statements, and the reported amount of expenses
during the reporting periods. Actual results could differ from those estimates.

 c. Consolidated financial statements in U.S dollars:

 The functional currency is the currency that best reflects the economic
environment in which the Company and its subsidiary operates and conducts their transactions. The Company's functional currency
is the U.S. dollar. The functional currency of CR Ltd is the New Israeli Shekel.

 Accordingly, monetary accounts maintained in currencies other than
the U.S. dollar are remeasured into U.S. dollars at each reporting period end in accordance with ASC No. 830 "Foreign Currency Matters."
All transaction gains and losses of the remeasured monetary balance sheet items are reflected in the statements of comprehensive loss
as financing income or expenses as appropriate.

 d. Principle of consolidation:

 The consolidated financial statements
include the accounts of the Company and its subsidiaries. All intercompany balances and transactions have been eliminated upon consolidation.

 e. Cash and cash equivalents:

 Cash equivalents are short-term highly
liquid deposits that are readily convertible to cash with original maturities of three months or less, at the date acquired, and investments
with maturities of longer than three months where the investment can be liquidated before the maturity date without a significant penalty.

 F- 9

2023

 U.S. dollars in thousands except share and per share data

 NOTE 2 – SUMMARY OF SIGNIFICANT
ACCOUNTING POLICIES (Continued)

 f. Equity method investments:

 The Company accounts for its investments
in common stock and in-substance common stock in accordance with ASC 323, Investments – Equity Method and Joint Ventures. Investments
in entities over which the Company does not have a controlling financial interest but has significant influence, are accounted for using
the equity method, with the Company's equity in losses reported in equity in losses from investment in affiliate on the statements
of comprehensive loss. Equity method investments are recorded at cost, plus the Company's share of earnings or losses, and impairment,
if any, within investment in an affiliate on the balance sheets. The Company evaluates its equity investments for impairment at each reporting
period. If qualitative factors indicate that the investment is impaired and its fair value is less than the carrying value, the Company
recognizes an impairment loss in earnings.

 g. Fair value of financial instruments:

 The accounting guidance for fair value
provides a framework for measuring fair value, clarifies the definition of fair value, and expands disclosures regarding fair value measurements.
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly
transaction between market participants at the reporting date. The accounting guidance establishes a three-tiered hierarchy, which prioritizes
the inputs used in the valuation methodologies in measuring fair value as follows:

 Level 1

 —

 Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.

 Level 2

 —

 Observable inputs that are based on inputs not quoted on active markets but corroborated by market data.

 Level 3

 —

 Unobservable inputs are used when little or no market data are available.

 The carrying amounts of cash, other accounts receivables, loan to an
affiliate, accounts payable, other current liabilities, short term loans and payables to related parties approximate their fair value
due to the short-term maturity of such instruments.

 h. Stock-based compensation:

 The Company accounts for stock-based
compensation awards issued to employees, directors, and non-employee consultants in accordance with ASC No. 718, "Compensation –
Stock Compensation" based on the fair value of the awards at the grant date. The Company has selected the Black-Scholes option-pricing
model as the most appropriate fair value method for its stock option and warrants awards. The fair value of the award is recognized as
an expense over the requisite service periods, which is the vesting period of the respective award, on a straight-line basis when the
only condition to vesting is continued service.

 The Company also granted certain awards that have both service-based
vesting conditions and performance-based vesting conditions. For these awards, we recognize stock-based compensation expense
on a graded basis over the total requisite service period for each separately vesting portion of performance tranches where it is probable
that the performance-based vesting conditions will be achieved. The Company recognizes forfeitures of the awards as they occur.

 F- 10

2023

 U.S. dollars in thousands except share and per share data

 NOTE 2 – SUMMARY OF SIGNIFICANT
ACCOUNTING POLICIES (Continued)

 i. Basic and diluted net loss per Share:

 The Company's
basic net loss per share is calculated by dividing net loss by the weighted-average number of shares
of common shares outstanding for the period, without consideration of potentially dilutive securities. The diluted net loss per share
is calculated by giving effect to all potentially dilutive securities outstanding for the period using the treasury share method or the
if-converted method based on the nature of such securities. Diluted net loss per share is the same as basic net loss per share in periods
when the effects of potentially dilutive common shares are anti-dilutive.

 j. Research and Development costs:

 Research and development costs are recognized
in the consolidated statements of comprehensive loss when incurred. Research and development costs consist of intellectual property, development
and production expenditures.

 k. Royalty-bearing grants:

 Royalty-bearing grants from the IIA
for funding approved research and development projects are recognized at the time CR Ltd is entitled to such grants (i.e. at the time
that there is reasonable assurance that the Company will comply with the conditions attached to the grant and that there is reasonable
assurance that the grant will be received), on the basis of the costs incurred and grants received are recorded as a reduction in research
and development costs. The cumulative research and development grants received by the Company from inception through December 31, 2024,
amounted to $ 135. These amounts were deducted from research and development costs in the consolidated statements of comprehensive
loss for the years ended December 31, 2024, and 2023 ($ 58, and $ 77, respectively).

 l. Income Taxes:

 The Company accounts for income taxes
in accordance with ASC 740, "Income Taxes", which prescribes the use of the liability method whereby deferred tax asset and
liability account balances are determined based on differences between the financial reporting and tax bases of assets and liabilities
and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company
provides a valuation allowance, to reduce deferred tax assets to their estimated realizable value, if needed.

 The Company also accounts for
uncertain tax positions under ASC 740. ASC 740 offers a two-step approach for recognizing and measuring a liability for uncertain
tax positions. The first step is to evaluate the tax position taken or expected to be taken in a tax return by determining if the
weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical merits, the tax
position will be sustained on audit, including resolution of any related appeals or litigation processes. The second step is to
measure the tax benefit as the largest amount that is more than 50 % likely to be realized upon ultimate settlement. As of December
31, 2024 and 2023, no liability for unrecognized tax benefits was recorded under ASC 740.

 F- 11

2023

 NOTE 2 – SUMMARY OF SIGNIFICANT
ACCOUNTING POLICIES (Continued)

 m. Recently issued and adopted accounting standards:

 As an "emerging growth company,"
the Jumpstart Our Business Startups Act ("JOBS Act") allows the Company to delay adoption of new or revised accounting pronouncements
applicable to public companies until such pronouncements are made applicable to private companies. The Company has elected to use this
extended transition period under the JOBS Act. The adoption dates discussed below reflects this election.

 1.

 In
 November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280), Improvements to Reportable Segment Disclosures, which
 expands annual and interim disclosure requirements for reportable segments, primarily through enhanced disclosures about significant
 segment expenses. In addition, it provides new segment disclosure requirements for entities with a single reportable segment. The
 guidance will be effective for the Company for annual periods beginning January 1, 2024 and for interim periods beginning January
 1, 2025. The adoption of the standard did not have a material impact on the financial statements.

 n. Recently issued and not yet adopted accounting standards:

 1.

 In December 2023, the FASB issued ASU 2023-09, Income taxes (topic 740): Improvements to Income Tax Disclosures. The guides require disclosure of a tabular reconciliation, using both percentages and reporting currency amounts. Additional disclosers are required such as income taxes paid, Income (or loss) from continuing operations before income tax expense (or benefit) disaggregated between domestic and foreign and Income tax expense (or benefit) from continuing operations disaggregated by federal (national), state, and foreign. The guidance will be effective for the Company for fiscal years beginning after December 15, 2024. Early adoption is permitted. Adoption of the new standard will not have a material impact on the financial statements.

 2.

 In November 2024, the FASB issued ASU 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40), Disaggregation of Income Statement Expenses. The new guidance requires disclosure of certain costs and expenses in the notes to the financial statements. This guidance is effective for fiscal years beginning after December 15, 2026 and interim reporting periods beginning after December 15, 2027. Early adoption is permitted. The disclosures required under the guidance can be applied either prospectively to financial statements issued for reporting periods after the effective date or retrospectively to any or all periods presented in the financial statements. The Company is currently evaluating the impact this guidance will have on its financial statement disclosures.

 F- 12

2023

 NOTE 3 – INVESTMENT IN AN AFFILIATE

 a.
 On April 24, 2021, CR Ltd. invested $ 250 representing 19.99 % of the
share capital of Revoltz Ltd. ("Revoltz"), an Israeli private company focusing on research, development and production of
micro-mobility vehicles for the urban environment for the business and the private markets.

 b.
 On July 28, 2022, CR Ltd. entered into a convertible loan agreement
with Revoltz pursuant to which CR Ltd. was required to loan an amount of $ 60 (the "Loan Principal Amount") in Revoltz. In
addition, CR Ltd. will provide an additional loan to Revoltz in an amount of up to $ 340 (the "Additional Amount" and, together
with the Loan Principal Amount, the "Total Loan Amount"). The Total Loan Amount will carry interest at the minimum rate prescribed
by Israeli law.

 The Total Loan Amount will be converted into shares of Revoltz
upon the occurrence of any of the following events (each, a "Trigger Event"):

 i)
 The consummation of funding by Revoltz of an aggregate amount of $ 1,000 at a pre-money Revoltz valuation of at least $ 7,000 (in the form of Simple Agreement for Future Equity, equity or otherwise); or

 ii)
 Revoltz has generated an aggregate of $ 1,000 or more in revenue.

 In the event that a Trigger Event will
not occur on or prior to the 24-month anniversary of the date on which the Loan Principal Amount is actually extended to Revoltz, the
loan will be due and repayable by Revoltz to the Company.

 On December 31, 2024, the balance of
the Loan Principal Amount granted and accrued interest, was $ 64. To date, no Additional Amounts have been funded.

 c.
 The following table summarizes the equity method accounting for the
investment in Revoltz:

 Balance, January 1, 2023

 $

 Equity in losses

 ( 27
)

 Foreign currency translation

 ( 15
)

 Balance, December 31, 2023

 Equity in losses

 ( 36
)

 Foreign currency translation

 ( 1
)

 Balance, December 31, 2024

 $

 F- 13

2023

 NOTE 4 – RELATED PARTIES

 a.

 In support of the Company's efforts and cash requirements, the
Company receives advances from related parties until such a time that the Company can support its operations or attains adequate financing
through sales of stock or traditional debt financing. There is no formal written commitment for continued support by related parties.

 Payables to related parties:

 2024

 2023

 Consulting fees to executive officers

 $

 $

 Directors

 Xylo (see note 4c)

 $

 $

 b.

 Our corporate headquarters are located at 20 Raul Wallenberg Street, Tel Aviv, Israel 6971916, under a lease held by our shareholders, which the Company is using free of rent.

 c.
 As of January 1, 2023, CR Ltd. owed to Xylo Technologies Ltd. ("Xylo"), a related party, who holds the majority of the Company's common stock, $ 550 (the "Xylo Loan"). The Xylo Loan bears interest in accordance with section 3(i) of the Israeli tax code ( 2.42 % annually during 2022) and no fixed date for repayment has been determined. On January 1, 2023, CR Ltd. and Xylo signed an agreement to amend the terms of the Xylo Loan (the "Xylo Loan Agreement"). Pursuant to the Xylo Loan Agreement, the interest rate remains unchanged, and the principal and interest is payable in cash or shares, or a combination thereof by June 30, 2023. On April 4, 2023, the Xylo Loan balance was $ 553. The $ 509 of the Xylo Loan was converted into 28 shares of CR Ltd. (representing 1,206,834 shares of the Company) and the remaining Xylo Loan balance becomes payable in cash. The Company is in discussions with Xylo to extend the repayment date of the remaining Xylo Loan balance.

 F- 14

2023

 NOTE 5 – COMMON STOCK AND PREFERRED SHARES

 a.
 The Company's share capital is as follows:

 December 31, 2024

 December 31, 2023

 Authorized

 Issued and

 Authorized

 Issued and

 Common stock

 50,000,000

 9,564,351

 2,990,000,000

 9,152,228

 Preferred shares

 10,000,000

 -

 10,000,000

 -

 On March 22, 2022, the Company amended its Certificate
of Incorporation and increased the number of authorized shares to 3,000,000,000 shares with a par value of $ 0.0001 of which 2,990,000,000
shares were be common stock with a par value of $ 0.0001 and 10,000,000 shares were preferred share with a par value of $ 0.0001.

 On December 2, 2024, the Company amended its Certificate
of Incorporation and decreased the number of authorized shares to 60,000,000 shares with a par value of $ 0.0001 of which 50,000,000 shares
are common stock with a par value of $ 0.0001 and 10,000,000 shares are preferred shares with a par value of $ 0.0001.

 There were no preferred shares outstanding as
of December 31, 2024 and 2023.

 Each common stock is entitled to receive dividends,
participate in the distribution of the Company's net assets upon liquidation and to receive notices of participation and voting
(at one vote per share) at the general meetings of the Company's shareholders on any matter upon which the general meeting
is authorized to be held.

 Pursuant to Note 1, upon the consummation of the Acquisition Agreement,
CR Ltd. became a wholly-owned subsidiary of the Company and former shareholders of CR Ltd. received 72.88 % of the issued and outstanding
common stock of the Company. On April 4, 2023, the Acquisition closed, and the former shareholders of CR Ltd. were issued 6,146,188 common
stock of the Company.

 On April 3, 2023, prior to the Closing of the
Acquisition Agreement (see Note 1), CR Ltd. issued an aggregate of 15 shares of CR Ltd., representing 628,045 common stock of the Company,
in respect of stock options exercised by stock option holders, for total proceeds of $ 91.

 On April 3, 2023, prior to the Closing of the
Acquisition Agreement, the Company issued 28 shares of CR Ltd., representing 1,206,834 shares of the Company, in respect of a conversion
of a from a related party (see Note 6c).

 On April 6, 2023, the Company issued a total of
 910,000 common stock to three investors for the total amount of $ 501.

 On July 4, 2023, the Company approved its 2023
Equity Incentive Plan (the "Plan") for the directors, officers, consultants and employees of the Company and its subsidiaries.
The maximum number of stock options and restricted share units ("RSU") issuable under the Plan is 1,372,656 shares of the
outstanding common stock of the Company. As of the date of this report, no stock options or RSUs have been issued under the Plan.

 In December 2024, the Company issued 412,123 shares
of common stock in a private placement offering for a total of $ 410.

 F- 15

2023

 NOTE 5 – COMMON STOCK AND PREFERRED STOCK
(Continued)

 b.

 Warrants:

 1.
 Pursuant to the Acquisition, the Company issued to the former shareholders of CR Ltd. 6,150,000 warrants,
which warrants are exercisable upon the Company achieving each of the three (3) performance milestones (collectively, the "Earn
Out Milestones") as follows:

 (i)

 In-house demonstration for automatic robotic charging of an electric vehicle – until December 31, 2025.

 (ii)

 Conditional Purchase Order for first system for automatic car parks – until December 31, 2025.

 (iii)

 Commercial agreement for pilot with an organization which was approved by the Company's board – until December 31, 2025.

 Without limiting the generality of the
Earn Out Milestones, all of the warrants will become immediately exercisable upon the Company's successfully listing its common
stock on the Nasdaq Stock exchange.

 2.
 On June
20, 2024, the Company issued 122,831 warrants to Automax Motors Ltd. (the "Automax Warrants") with an exercise price of $ 12.82
in exchange for services received. The Automax Warrants expire on September 20, 2027. The Automax Warrants were accounted for as stock-based
compensation. The fair value of the Automax Warrants was $ 19, using the Black-Scholes warrant pricing model using the following assumptions:

 June 20,
 2024

 Company common stock price

 $
 0.55

 Exercise price

 $
 12.82

 Dividend yield

 %

 Risk-free interest rate

 4.46
 %

 Expected term (in years)

 3.25

 Volatility

 %

 c.

 Stock
options in the Company

 As of December 31, 2024 and 2023, there
are no outstanding stock options in the Company.

 d.

 Share options in CR Ltd.

 On February 1, 2022, CR Ltd. issued 4 stock options to Ben Gurion University
(the "BGU Options") with an exercise price of $ 0.01. The BGU Options entitle the option holder to receive 72,295 shares of
the Company, and expire on January 1, 2032. The fair value of the BGU Options issued was $ 30, using the Black-Scholes option pricing model.
A third of the stock options vested on June 30, 2023, and the remaining stock options vest on a quarterly basis over a period of 10 quarters,
commencing on September 30, 2023, and ending on December 31, 2025. On August 28, 2024, the Company and Ben Gurion University signed a
License and Settlement Agreement (the "Settlement Agreement"). According to the Settlement Agreement the BGU Options are forfeited
and expired.

 For the year ended December 31, 2024, the Company recorded income in
the amount of $ 24 in stock-based compensation expenses in respect of the BGU Options, as a result of the cancellation of expenses recognized
in previous year in respect of the BGU Options (during the year ended December 31, 2023 - $ 10).

 A summary of stock options activity during the
period is as follows:

 Number

 Average
 weighted
 exercise price

 Options outstanding as of December 31, 2023

 $
 0.01

 Options outstanding as of December 31, 2024

 -

 $
 -

 F- 16

2023

 NOTE 5 – COMMON STOCK AND PREFERRED STOCK
(Continued)

 The following CR Ltd. options are outstanding as of December 31, 2023
and 2024:

 Issuance date

 Options

 Exercise
 price per
 option

 Options
 exercisable

 Expiry date

 January 1, 2022

 $
 0.01

 January 1, 2032

 NOTE 6: LIENS AND COMMITMENTS

 CR Ltd. is committed to pay royalties to the IIA on the proceeds from
sales of products resulting from research and development projects in which the IIA participates by way of grants. In the first 3 years
of sales, the Company will pay 3 % of the sales of the product which was developed under IIA research and development projects. In the
fourth, fifth and sixth years of sales, the Company will pay 4 % of such sales and from the seventh year onwards the Company will pay 5 %
of up to 100 % of the amount of grants received plus interest at LIBOR. CR Ltd. was entitled to the grants only upon incurring research
and development expenditures. There are no future performance obligations related to the grants received from the IIA. As of December
31, 2024, the contingent liabilities with respect to grants received from the IIA, subject to repayment under these royalty agreements
on future sales is $ Nil. As of December 31, 2024, CR Ltd. received a total of $ 135 from the IIA.

 NOTE 7 – INCOME TAXES

 a.

 Corporate tax rates in Israel:

 The Israeli statutory corporate tax
rate was 23 % in both 2024 and 2023. The Company's tax assessments since its inception are not deemed final.

 b.

 Deferred income taxes:

 Deferred income taxes reflect the net
tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts
used for income tax purposes. Significant components of the Company's deferred tax assets are as follows:

 2024

 2023

 Deferred tax assets:

 Carry forward tax losses

 $
 1,598

 $

 Net deferred tax asset before valuation allowance

 1,598

 Valuation allowance

 ( 1,598
)

 ( 905
)

 Income tax benefit at the statutory tax rate

 $
 -

 $
 -

 In assessing the realization of deferred
tax assets, management considers whether it is more likely than not that all or some portion of the deferred tax assets will not be realized.
The ultimate realization of the deferred tax assets is dependent upon the generation of future taxable income during the periods in which
temporary differences are deductible and net operating losses are utilized. Based on consideration of these factors, the Company recorded
a full valuation allowance as of December 31, 2024.

 F- 17

2023

 c.

 Net operating carry-forward losses for tax purposes:

 As of December 31, 2024, the Company's
carry-forward losses amount to approximately $ 1,598, which can be carried forward for an indefinite period.

 NOTE 8 – SEGMENT REPORTING

 Segment information is prepared on the same basis
that the Chief Executive Officer, who is the Company's Chief Operating Decision Maker ("CODM"), manages the business,
makes business decisions and assesses performance. The Company has one reportable segment specializing in development of an innovative
wireless electric vehicles (EV) charging technology as described in Note 1B.

 The Chief Executive Officer assesses performance
for this segment and decides how to allocate resource. The measure of segment assets is reported on the balance sheet as total assets.
The chief executive officer performs the assessment of segment performance by using the reported measure of segment profit or loss to
monitor budget versus actual results.

 The table below summarizes the significant expense
categories regularly reviewed by the CODM for the years ended December 31, 2024 and 2023:

 2024

 2023

 Research and development costs, net

 $

 $

 General and administrative costs

 Other segment items:

 Financial expenses

 Equity in losses from investment in affiliate

 $

 $

 NOTE 9 – REVISION OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS

 The Company's consolidated financial statements
for the year ended December 31, 2023 have been revised for the effect of certain adjustments that were made in the preparation of financial
statements for the year ended December 31, 2024:

 (1)
 In the financial statements for the year ended December 31, 2023, the Company had capitalized certain
payments made for patents registration, and recorded the amounts as an intangible assets. During the year ended December 31, 2024, the
Company reconsidered this assessment and believes that these amounts should be expensed. As a consequence, the Company revised its financial
statements to remove the intangible asset and adjust retained earnings for periods beginning in 2021 through the third quarter of 2024
in the cumulative amount of $ 104.

 (2)
 In March 2023, the Company entered into an Acquisition Agreement (see note 1B) pursuant to which it acquired
 100 % of the shares of CR Ltd. In the Consolidated Statements of Stockholders' Deficit, an incorrect numbers and amount of common
stock were allocated to the "Effect of the reverse recapitalization", which have been corrected in these consolidated financial
statements. The total number of common stock issued in the transaction did not change.

 The Company have evaluated the materiality of the intangible asset
and common stock impact quantitatively and qualitatively and concluded it was not material to any of the prior periods impacted. The Company
elected to revise previously issued consolidated financial statements contained within this Annual Report on Form 10-K for the periods
impacted to correct the effect of this immaterial intangible asset and common stock for the corresponding periods.

 NOTE 10 – SUBSEQUENT EVENTS

 The Company determined that it does not have subsequent
event requiring recording or disclosure in the financial statements for the year ended December 31, 2024, other than described below:

 a.
 In January
2025, the Company rented an office, lab and assembly and integration area in an innovation and startup hub located in "The Rupin
Technological Campus", approximately 40km north of Tel Aviv. The monthly rental fee is 4,000 NIS (approximately $ 1.1) per month.
The lease term requires only one month termination notice.

 b.
 On January 15, 2025, the Company issued 30,303 common stock to an investor for $ 50.

 c.
 On March 6, 2025, CR Ltd. received an additional $ 31 in grants from the IIA.

 d.
 On March 23, 2025, the Company issued 124,604 common stock to an investors for $ 206. The Company also issued 111,689 shares to consultants in respect of finders' fees for previous private placements.

 F- 18

 ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS
AND FINANCIAL DISCLOSURE

 There has been no change in independent accountants
for our Company during the two most recent fiscal years or any subsequent interim period except as previously reported in the Company's
Current Report on Form 8-K filed with the SEC on March 12, 2025. There were no disagreements with accountants on accounting and financial
disclosure of a type described in Item 304 (a)(1)(iv) or any reportable event as described in Item 304 (a)(1)(v) of Regulation S-K.

 ITEM 9A. CONTROLS AND PROCEDURES

 Evaluation of Disclosure Controls and Procedures

 We carried out an evaluation, under the supervision
and with the participation of our management, including our chief executive officer and chief financial officer, of the effectiveness
of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange
Act. Disclosure controls and procedures include, without limitation, means controls and other procedures that are designed to ensure that
information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is (i) recorded, processed,
summarized and reported, within the time periods specified in the Commission's rules and forms and (ii) accumulated and communicated
to the issuer's management, including its principal executive and principal financial officers, or persons performing similar functions,
as appropriate to allow timely decisions regarding required disclosure. Based on this evaluation, because of the Company's limited
resources and lack of employees, management, including our chief executive officer and chief financial officer, concluded that our disclosure
controls and procedures were ineffective as of December 31, 2024.

 Management has identified control deficiencies
regarding inadequate accounting resources, the lack of segregation of duties and the need for a stronger internal control environment.
Management of the Company believes that these material weaknesses are due to the small size of the Company's outsourced accounting
staff. The small size of the Company's accounting outsourced staff may prevent adequate controls in the future due to the cost/benefit
of such remediation.

 To mitigate the current limited resources and
limited employees, we rely heavily on direct management oversight of transactions, along with the use of external legal and accounting
professionals. As we grow, we expect to increase our number of employees, which will enable us to implement adequate segregation of duties
within the internal control framework.

 These control deficiencies could result in a misstatement
of account balances that would result in a reasonable possibility that a material misstatement to our consolidated financial statements
may not be prevented or detected on a timely basis. In light of this material weakness, we performed additional analyses and procedures
in order to conclude that our consolidated financial statements for the year ended December 31, 2024, included in this Annual Report on
Form 10-K were fairly stated in accordance with GAAP. Accordingly, management believes that despite our material weaknesses, our consolidated
financial statements for the year ended December 31, 2024, are fairly stated, in all material respects, in accordance with GAAP.

 Management's Report on Internal Control
Over Financial Reporting

 Our management is responsible for establishing
and maintaining adequate internal control over financial reporting. Internal control over financial reporting is defined in Rule 13a-15(f)
or 15d-15(f) promulgated under the Securities Exchange Act of 1934 as a process designed by, or under the supervision of, the Company's
principal executive and financial officers and effected by the Company's board of directors, management and other personnel, to
provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external
purposes in accordance with generally accepted accounting principles and includes those policies and procedures that:

 Pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of the Company;

 Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and

 Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company's assets that could have a material effect on the financial statements.

 Because of its inherent limitations, internal
control over financial reporting may not prevent or detect misstatements. Projections of any evaluation of effectiveness to future periods
are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the
policies or procedures may deteriorate.

 In connection with this assessment, the Company
reports the material weakness, as described below, in internal control over financial reporting as of December 31, 2024. Management
has identified material weaknesses regarding inadequate accounting resources, the lack of segregation of duties and the need for a stronger
internal control environment. Management of the Company believes that these material weaknesses are due to the small size of the Company's
outsourced accounting staff. The small size of the Company's accounting outsourced staff may prevent adequate controls in the future
due to the cost/benefit of such remediation. A material weakness is a deficiency, or a combination of deficiencies, in internal
control over financial reporting, such that there is a reasonable possibility that a material misstatement for the annual or interim financial
statements will not be prevented or detected on a timely basis. Because of the material weakness described above, and based
on management's assessment, as of December 31, 2024, the Company's internal control over financial reporting was not effective.

 Notwithstanding the material weakness,
we believe that our financial statements contained in this report fairly present our financial position, results of operations and cash
flows for the periods covered by this report in all material respects.

 Our management has initiated steps and plans to
take additional measures to remediate the underlying causes of the material weakness.

 Planned Remediation of Material Weaknesses

 Our management has been actively engaged in developing
and implementing remediation plans to address the material weaknesses described above. These remediation efforts are ongoing and include
or are expected to include:

 engaging internal control consultants to assist us in performing a financial reporting risk assessment as well as identifying and designing our system of internal controls necessary to mitigate the risks identified;

 preparation of written documentation of our internal control policies and procedures;

 until we have sufficient technical accounting resources, we have engaged external consultants to provide support and to assist us in our evaluation of more complex applications of GAAP.

 We continue to enhance corporate oversight over
process-level controls and structures to ensure that there is appropriate assignment of authority, responsibility, and accountability
to enable remediation of our material weaknesses. We believe that our remediation plan will be sufficient to remediate the identified
material weaknesses and strengthen our internal control over financial reporting. As we continue to evaluate, and work to improve, our
internal control over financial reporting, management may determine that additional measures to address control deficiencies or modifications
to the remediation plan are necessary.

 Limitations on Effectiveness of Controls and Procedures

 Our management, including our principal executive
officer and principal financial officer, does not expect that our disclosure controls and procedures or our internal controls will prevent
all errors and all fraud. Further, the design of a control system must reflect the fact that there are resource constraints and the benefits
of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls
can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected. These inherent
limitations include, but are not limited to, the realities that judgments in decision-making can be faulty and that breakdowns can occur
because of simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of
two or more people, or by management override of the control. The design of any system of controls also is based in part upon certain
assumptions about the likelihood of future events and there can be no assurance that any design will succeed in achieving its stated goals
under all potential future conditions. Over time, controls may become inadequate because of changes in conditions, or the degree of compliance
with the policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements
due to error or fraud may occur and not be detected.

 Changes in Internal Control Over Financial
Reporting

 No changes in the Company's internal control
over financial reporting have come to management's attention during the Company's fiscal year ended December 31, 2024, that
have materially affected, or are likely to materially affect, the Company's internal control over financial reporting.

 ITEM 9B. OTHER INFORMATION

 None.

 Item 9C. Disclosure Regarding
Foreign Jurisdictions that Prevent Inspections

 ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND
CORPORATE GOVERNANCE

 The following table sets forth the name, age and
positions of our executive officers and directors.

 NAME

 Age

 POSITION

 Chief Financial Officer

 Yakov Baranes

 Eliyahu Yoresh

 Amitay Weiss

 Tali Dinar

 The business background and certain other information about our directors
and executive officers is set forth below:

 Hovav Gilan served as our CEO since April
2023. Hovav also serves as the CEO of CR Israel, our wholly-owned subsidiary since its inception in 2021. Hovav
has an engineering degree in Chemical Engineering and Chemistry from the Technion Israeli Institute of Technology as well as an MBA from
the University of Liverpool UK. Prior to joining CR Israel, Hovav founded and managed a water treatment company. Before
that Hovav held various business development, sales and marketing positions as well as technical roles all in companies in the field of
equipment for the semiconductor industry. Hovav served as application manager for Asia and Europe with Nova measuring instruments
Ltd (NASDAQ NVMI).

 Gadi Levin has served as our Chief Financial
Officer since January 26, 2022. Mr. Levin also serves as a director and CFO of various publicly listed companies in the US and Canada.
He has over 15 years of experience working with public US, Canadian and multi-jurisdictional public companies. Previously, Mr. Levin also
served as the Vice President of Finance and Chief Financial Officer for two Israeli investment firms specializing in private equity, hedge
funds and real estate. Mr. Levin began his CPA career at the accounting firm Arthur Andersen, where he worked for nine years, specializing
in U.S. listed companies involved in IPOs. Mr. Levin has a Bachelor of Commerce degree in Accounting and Information Systems from the
University of the Cape Town, South Africa in 1993, and a post graduate diploma in Accounting from the University of South Africa in 1995.
He received his Chartered Accountant designation in South Africa in 1998 and has an MBA from Bar Ilan University in Israel, which he received
in 2006.

 Yakov Baranes has served as a member of
our board of directors since April 7, 2023. Mr. Baranes Business strategy expert with a demonstrated 11 years history of working with
various industries and government entities. Skilled in business strategy planning and implementations on a corporate level and business
unit level. Working also with start- up companies in shaping their business plans and supporting their capital raising rounds. Holds a
Bachelor of Arts (B.A.) in Economics from the Technion - Israel Institute of Technology and a MBA from IDC, Herzliya.

 Eliyahu Yoresh has served as a member of
our board of directors since April 7, 2023. Mr. Yoresh also serves as a member of the board of Xylo Technologies Ltd ("Xylo",
Nasdaq: XYLO) since September 2018 and as Xylo Chairman of the board since February 2020. Mr. Yoresh serves as chief financial officer
of Foresight Autonomous Holdings Ltd. (Nasdaq, TASE: FRSX). In addition, Mr. Yoresh serves as a director of Rail Vision Ltd (Nasdaq: RVSN),
Jeff Brands Ltd (Nasdaq: JFBR), Viewbix Inx (OTC: VBIX), Elbit Imaging Ltd (TASE: EMITF) and Gix (TASE: GIX) Mr. Yoresh served as the
chief executive officer of Tomcar Global Holdings Ltd., a global manufacturer of off-road vehicles, from 2005 to 2008. Mr. Yoresh is an
Israeli Certified Public Accountant. Yoresh acquired a B.A. in business administration from the Business College, Israel and an M.A. in
Law Study from Bar-Ilan University, Israel.

 Amitay Weiss has served as a member of
our board of directors since January 6, 2022. Mr. Weiss Weiss has served Chairman of the Board of Directors of Scispacr Ltd since August
19, 2019. Mr. Weiss served as the Chief Executive Officer of SciSparc Ltd. from August 2020 until January 2022, and since January 2022,
Mr. Weiss has served as the Chairman of SciScparc's Board of Directors. In addition, Mr. Weiss currently serves as Chairman of the
Board of Directors of both Automax Ltd. (TASE: AMX) and Save Foods, Inc. In 2016, Mr. Weiss founded Amitay Weiss Management Ltd. and now
serves as its chief executive officer. From 2001 until 2015, Mr. Weiss served as vice president of business marketing & development
and in various other positions at Bank Poalei Agudat Israel Ltd. from the First International Bank of Israel group. Mr. Weiss holds a
B.A. in economics from New England College, an M.B.A. in business administration from Ono Academic College in Israel, an Israeli branch
of University of Manchester and an LL.B from the Ono Academic College.

 Tali Dinar has served as a member of our
board of directors since April 7, 2023. Since 2021, Ms. Dinar has served as Chief Financial Officer of Xylo, the Company's former
parent company. Ms. Dinar also serves served as Chief Financial Officer of Novomic Ltd., a private company since between January 2019
and January 2023. Mrs. Dinar also currently serves as a member of the board of directors of Jeffs' Brands, beginning September 30,
2021, and Parazero Ltd. beginning February 13, 2022 and Charging Robotics Ltd. since November 2021. She has also served as a member of
the board of directors of Micronet Ltd. (TASE: MCRNT) since between July 2016 and February 2023. Between 2019 and 2020, Mrs. Dinar served
as the Chief Financial Officer of TechCare Corp. (currently Citrine Global Corp.) (OTCQB: CTGL). Between 2009 and 2019, Mrs. Dinar worked
at the MICT group and served in various positions, including as Chief Financial Officer of MICT Inc. (Nasdaq: MICT) and as Chief Financial
Officer of MICT Telematics Ltd. From 2002 until 2006, Ms. Dinar served as the chief controller of I.T.L. Optronics Ltd. From 1997 until
2000, Ms. Dinar worked in the audit department of Ernst & Young Global. Ms. Dinar is a certified public accountant in Israel and holds
a B.A. degree in Accounting and Business Management from The College of Management, Israel.

 Family Relationships

 There are no family relationships among any of
the Company's directors and officers.

 Involvement in Certain Legal Proceedings

 We are not aware of any of our directors or officers
being involved in any legal proceedings in the past ten years relating to any matters in bankruptcy, insolvency, criminal proceedings
(other than traffic and other minor offenses), or being subject to any of the items set forth under Item 401(f) of Regulation S-K.

 Arrangements between Officers and Directors

 To our knowledge, there is no arrangement or understanding
between any of our officers and any other person, including directors, pursuant to which the officer was selected to serve as an officer.
However, some of our directors are also directors of Medigus Ltd., which is one of our major shareholders.

 Board of Directors

 There are no agreements with respect to the election
of directors.

 Insider Trading Policy

 We have adopted a statement of trading policies
that governs the trading in our securities by our directors, officers and certain other covered persons, and which is reasonably designed
to promote compliance with applicable insider trading laws, rules and regulations, and any listing standards applicable to the Company.
A copy of the Insider Trading Policy is included as Exhibit 19.1 to this annual report. In addition, with regard to any trading in our
own securities, it is our policy to comply with the federal securities laws and the applicable exchange listing requirements.

 ITEM 11. EXECUTIVE COMPENSATION

 Summary Compensation Table

 The following sets forth the compensation paid
by us to our named executive officers, during the years ended December 31, 2024, and December 31, 2023.

 Name and Principal Position

 Year

 Salary
 ($) (1)

 Bonus
 ($)

 Stock
 Awards
 ($)

 Option
 Awards
 ($) (2)

 All Other
 Compensation
 ($)

 Total
 ($)

 Hovav Gilan (2)

 2024

 80,000

 -

 -

 -

 -

 80,000

 2023

 87,000

 -

 -

 -

 -

 87,000

 Amitay Weiss (3)

 2024

 -

 -

 -

 -

 -

 -

 2023

 -

 -

 -

 -

 -

 -

 2024

 36,000

 -

 -

 -

 -

 36,000

 Chief Financial Officer

 2023

 44,000

 -

 -

 -

 -

 44,000

 (1)
 On
October 1, 2021, CR Israel signed a consulting agreement with its CEO, Mr. Hovav Gilan (the "CEO"), pursuant to which CR
Israel will pay the CEO a monthly fee of NIS 24,700 (approximately $7).

 (2)
 Hovav
Gilan's tenure as Chief Executive Officer began on April 7, 2023.

 (3)
 Amitay
Weiss's tenure as Chief Executive Officer ended on April 7, 2023.

 All Other Compensation Table

 The "All Other Compensation"
amounts set forth in the Summary Compensation Table above consist of the following:

 Name

 Year

 Automobile-
 Related
 Expenses
 ($)

 Manager's
 Insurance*
 ($)

 Education
 Fund*
 ($)

 Other social benefits**
 ($)

 Total
 ($)

 Hovav Gilan (1)

 2024

 -

 -

 -

 -

 -

 2023

 -

 -

 -

 -

 -

 Amitay Weiss (2)

 2024

 -

 -

 -

 -

 -

 2023

 -

 -

 -

 -

 -

 2024

 -

 -

 -

 -

 -

 2023

 -

 -

 -

 -

 -

 *

 Manager's insurance and education funds are customary benefits provided to employees based in Israel. Manager's insurance is a combination of severance savings (in accordance with Israeli law), defined contribution tax-qualified pension savings and disability insurance premiums. An education fund is a savings fund of pre-tax contributions to be used after a specified period of time for educational or other permitted purposes.

 **

 Other social benefits for 2024 and 2023 for all named individuals includes tax payments in respect of social benefits.

 (1)

 Hovav Gilan's tenure as Chief Executive Officer began on April 7, 2023.

 (2)

 Amitay Weiss's tenure as Chief Executive Officer ended on April 7, 2023.

 Agreements with Named Executive Officers

 On November 1, 2021, CR Israel, our wholly-owned
subsidiary, entered into a management agreement with Hovav Gilan, or the Gilan Management Agreement, pursuant to which Mr. Gilan will
serve as our Chief Executive Officer. Pursuant to the terms of the Gilan Management Agreement, Mr. Gilan receives NIS 24,700 per month
as his base salary and shall be eligible to receive such bonus as determined by us. The term of the Gilan Management Agreement shall be
effective as of October 1, 2021, and shall continue until such time either party provides written notice to the other party at least 60
days in advance of the termination of such agreement. We may also terminate Mr. Gilan's management without prior written notice
(or payment in lieu of such notice) for Cause (as defined in the Gilan Management Agreement).

 On February 1, 2022, CR entered
into a management agreement with Gadi Levin, or the Levin Management Agreement, pursuant to which Mr. Levin will serve as our Chief Financial
Officer. Pursuant to the terms of the Levin Management Agreement, Mr. Levin receives $3,000 per month as his base consulting fee and shall
be eligible to receive such bonus as determined by us. The term of the Levin Management Agreement became effective as of February 1, 2022,
and shall continue until such time either party provides written notice to the other party at least 60 days in advance of the termination
of such agreement. We may also terminate Mr. Levin's management without prior written notice (or payment in lieu of such notice)
for Cause (as defined in the Levin Management Agreement). On January 1, 2024, the base consulting fee was increased to $4,000 per month,
and from February 1, 2025, to $5,000 per month.

 Outstanding Equity Awards at Fiscal Year-End

 During the years ended December 31, 2023, and
December 31, 2024, our executive officers have neither been granted any options, nor did any unvested stock or options granted to executive
officers vest. As of the date of this report, our executive officers do not have any stock options or unvested shares of stock of
the Company.

 Director Compensation

 The following table sets forth compensation information
for our non-employee directors for the year ended December 31, 2024.

 Name

 Fees earned

 or paid in
 cash ($)(1)

 Option
 awards ($)

 Total ($)

 Yakov Baranes

 49,000

 -

 49,000

 Eliyahu Yoresh

 -

 Amitay Weiss

 -

 Tali Dinar

 -

 (1)

 Fees for the year 2024 are based on average US$/NIS representative exchange rates of NIS 3.699.

 We
compensate our non-employee directors for their service as a member of our board.

 Each non-employee director
is entitled to receive a monthly fee of $1,000. Non-employee directors are also reimbursed for their travel and reasonable out-of-pocket
expenses incurred in connection with attending board and committee meetings, to the extent that attendance is required by the board or
the committee(s) on which that director serves.

 ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL
OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

 Security Ownership of Certain Beneficial Holders
and Management

 The following table lists the number of shares
of common stock of the Company as of the date of this annual report that are beneficially owned by (i) each person or entity known to
the Company to be the beneficial owner of more than 5% of the outstanding common stock; (ii) each officer and director of the Company;
and (iii) all officers and directors as a group. Information relating to beneficial ownership of common stock by our principal stockholders
and management is based upon information furnished by each person using "beneficial ownership" concepts under the rules of
the Securities and Exchange Commission. Under these rules, a person is deemed to be a beneficial owner of a security if that person has
or shares voting power, which includes the power to vote or direct the voting of the security, or investment power, which includes the
power to vote or direct the voting of the security. The person is also deemed to be a beneficial owner of any security of which that person
has a right to acquire beneficial ownership within sixty (60) days. Under the rules of the SEC, more than one person may be deemed to
be a beneficial owner of the same securities, and a person may be deemed to be a beneficial owner of securities as to which he/she may
not have any pecuniary beneficial interest. Except as noted below, each person has sole voting and investment power.

 Unless otherwise indicated, the address of each
person or entity named below is c/o Charging Robotics Inc., 20 Raul Wallenberg Street, Tel Aviv, Israel.

 Name
 of Beneficial Owner (1)

 Shares
 of Common Stock Beneficially Owned

 Percentage of

Common

Stock Owned (2)

 Principal Stockholders:

 Xylo Technologies Ltd.

 6,116,955
 (3)

 63.96
 %

 E.G. Europe Properties Ltd.

 947,515
 (4)

 9.99
 %

 Executive officers and directors:

 -

 -
 %

 22,233
 (5)

 *
 %

 Yakov Baranes

 16,000
 (6)

 *
 %

 Eliyahu Yoresh

 80,000
 (7)

 *
 %

 Amitay Weiss

 -

 -
 %

 Tali Dinar

 -

 -
 %

 All Executive Officers and Directors as a Group
 (6 persons)

 118,233

 1.2
 %

 *
 Less
than 1%

 (1)
 The
address of each person is c/o Charging Robotics Inc., 20 Raul Wallenberg Street, Tel Aviv, Israel 6971916, unless otherwise indicated
herein.

 (2)
 The
calculation in this column is based upon 9,594,654 shares of common stock outstanding on March
12, 2025. Beneficial ownership is determined in accordance with the rules of the SEC and generally includes voting or investment
power with respect to the subject securities. Shares of common stock that are currently exercisable or exercisable within 60 days of
March 12, 2025, are deemed to be beneficially owned by the person holding such securities
for the purpose of computing the percentage beneficial ownership of such person, but are not treated as outstanding for the purpose of
computing the percentage beneficial ownership of any other person.

 (3)
of 6,116,955 shares.

 (4)
of 947,515 shares.

 (5)
of 22,233 shares.

 (6)
of 16,000 shares.

 (7)
of 80,000 shares.

 Change in Control

 We are not aware of any arrangement that might
result in a change in control in the future. We have no knowledge of any arrangements, including any pledge by any person of our securities,
the operation of which may at a subsequent date result in a change in the Company's control.

 Securities Authorized for Issuance Under Equity
Compensation Plans

 On July 25, 2023, our Board of Directors approved
the Company's 2023 Equity Incentive Plan, which was approved by our stockholders on July 16, 2023, together with the Company's
Sub-Plan – Israeli Taxpayers. The 2023 Equity Incentive Plan initially authorized the issuance of up to 1,372,656 shares of common
stock.

 ITEM 13. CERTAIN RELATIONSHIPS AND RELATED
TRANSACTIONS, AND DIRECTOR INDEPENDENCE

 There are no other transactions involving the
Company and any of its officers, directors, majority shareholders or other related persons or control persons that require disclosure
pursuant to Item 404(d) of Regulation S-K (§ 229.404(d)). We do not have an established policy regarding related transactions.

 Employment Agreements

 Options

 Restricted Stock Grants

 Shareholder Activism

 Indemnification Agreements and Directors'
and Officers' Liability Insurance

 We have entered into indemnification agreements
with each of our directors and executive officers. These agreements, among other things, require us to indemnify these individuals and,
in certain cases, affiliates of such individuals, to the fullest extent permitted by Delaware law against liabilities that may arise by
reason of their service to us or at our direction, and to advance expenses incurred as a result of any proceedings against them as to
which they could be indemnified. We also maintain an insurance policy that insures our directors and officers against certain liabilities,
including liabilities arising under applicable securities laws.

 Director Independence

 We are not currently subject to listing requirements
of any national securities exchange, which generally stipulates certain requirements that a majority of a company's Board of Directors
be classified as "independent". As a result, we are not at this time required to have our Board of Directors comprised of
a majority of "independent directors".

 ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES

 Elkana Amitai, CPA, located in Mitzpe Netofa,
Israel, PCAOB ID 6816, served as our independent registered public accounting firm for the year ended December 31, 2023 and in the subsequent
interim periods through March 10, 2025.

 On
March 10, 2025, Brightman Almagor Zohar & Co., a Firm in the Deloitte Global Network, was appointed as our principal independent
registered public accounting firm for the year ended December 31, 2024 and 2023.

 The following table provides information regarding
fees paid or to be paid by us to Brightman Almagor Zohar & Co. and Elkana Amitai, CPA For the Years Ended December 31, 2024 and
2023:

 Fee Category

 2024

 2023

 Audit Fees

 $
 95,000

 $
 32,000

 Tax Fees

 $
 -

 $
 3,000

 Audit-related Fees

 -

 -

 Total Fees

 $
 95,000

 $
 35,000

 Audit Fees: Audit Fees consist of fees
billed for professional services performed by our independent registered public accounting firms for the audit of our annual financial
statements.

 Tax
Fees: Tax Fees may consist of fees for professional services, including tax and VAT consulting and compliance performed by our independent
registered public accounting firms provided during the period.

 Audit Committee Administration of Engagement

 We have not established an audit committee and
therefore do not have an audit committee pre-approval policy with respect to the engagement of an accountant for audit or non-audit services
in place.

 ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES

 (a) Financial Statements

 The
financial statements required by this Item are included beginning at page FF-1.

 FINANCIAL STATEMENTS

 AS OF DECEMBER 31, 2024

 FF- 1

 FINANCIAL STATEMENTS

 AS OF DECEMBER 31, 2024

 Page

 REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 FF-3 - FF-4

 Balance Sheets

 FF- 5

 Statements of Operations

 FF- 6

 Statements of Changes in Shareholders' Deficit

 FF- 7

 Statements of Cash Flows

 FF- 8

 Notes to the Financial Statements

 FF-9 - FF-14

 FF- 2

 INDEPENDENT
AUDITOR'S REPORT

 To
the shareholders and the Board of Directors of Revoltz Ltd.

 Opinion

 We have audited the financial statements of Revoltz
Ltd. (the "Company"), which comprise the balance sheets as of December 31, 2024 and 2023, and the related statements of operations,
changes in Shareholders' deficit, and cash flows for the years then ended, and the related notes to the financial statements (collectively
referred to as the "financial statements").

 In our opinion, the accompanying
financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2024 and 2023,
and the results of its operations and its cash flows for the years then ended in accordance with accounting principles generally accepted
in the United States of America.

 Basis for Opinion

 We conducted our audits
in accordance with auditing standards generally accepted in the United States of America (GAAS). Our responsibilities under those standards
are further described in the Auditor's Responsibilities for the Audit of the Financial Statements section of our report. We are
required to be independent of the Company and to meet our other ethical responsibilities, in accordance with the relevant ethical requirements
relating to our audits. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit
opinion.

 Substantial Doubt About the Company's Ability
to Continue as a Going Concern

 The accompanying financial statements have been prepared
assuming that the Company will continue as a going concern. As discussed in Note 1.b to the financial statements, the Company has suffered
recurring losses from operations, has a net capital deficiency, and has stated that substantial doubt exists about the Company's
ability to continue as a going concern. Management's evaluation of the events and conditions and management's plans regarding
these matters are also described in Note 1.b. The financial statements do not include any adjustments that might result from the outcome
of this uncertainty. Our opinion is not modified with respect to this matter.

 Responsibilities of Management
for the Financial Statements

 Management is responsible
for the preparation and fair presentation of the financial statements in accordance with accounting principles generally accepted in the
United States of America, and for the design, implementation, and maintenance of internal control relevant to the preparation and fair
presentation of financial statements that are free from material misstatement, whether due to fraud or error.

 In preparing the financial
statements, management is required to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial
doubt about the Company's ability to continue as a going concern for one year after the date that the financial statements are issued.

 Auditor's Responsibilities
for the Audit of the Financial Statements

 Our objectives are to obtain
reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error,
and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not absolute
assurance and therefore is not a guarantee that an audit conducted in accordance with GAAS will always detect a material misstatement
when it exists. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as
fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control. Misstatements are
considered material if there is a substantial likelihood that, individually or in the aggregate, they would influence the judgment made
by a reasonable user based on the financial statements.

 FF- 3

 In performing an audit in
accordance with GAAS, we:

 Exercise
professional judgment and maintain professional skepticism throughout the audit.

 Identify
and assess the risks of material misstatement of the financial statements, whether due to fraud or error, and design and perform audit
procedures responsive to those risks. Such procedures include examining, on a test basis, evidence regarding the amounts and disclosures
in the financial statements.

 Obtain
an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances,
but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control. Accordingly, no such opinion
is expressed.

 Evaluate
the appropriateness of accounting policies used and the reasonableness of significant accounting estimates made by management, as well
as evaluate the overall presentation of the financial statements.

 Conclude
whether, in our judgment, there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company's
ability to continue as a going concern for a reasonable period of time.

 We
are required to communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit,
significant audit findings, and certain internal control-related matters that we identified during the audit.

 /s/ Brightman Almagor Zohar & Co.

 Brightman Almagor Zohar & Co.

 Certified Public Accountants

 A Firm in the Deloitte Global Network

 Tel
Aviv, Israel

 FF- 4

 BALANCE SHEETS

 December 31

 2024

 2023

 Note

 thousands of NIS

 ASSETS

 Current assets:

 Cash and cash equivalents

 Other receivables

 Inventory

 Non-current assets:

 Loan to related party

 Property and equipment, net

 TOTAL ASSETS

 LIABILITIES AND SHAREHOLDERS' DEFICIT

 Current liabilities:

 Trade accounts payables

 Loans from related parties

 6b, c

 Payables to related parties

 5b

 1,059

 Other payables

 Current maturities of long-term loan

 6a

 2,095

 1,234

 Non-current liabilities:

 Long-term loan, net of current maturities

 6a

 TOTAL LIABILITIES

 2,110

 1,281

 SHAREHOLDERS' DEFICIT:

 Ordinary shares, NIS 0.01 par value; Authorized 1,000,000 shares; Issued and outstanding: 105,260 and 100,000 shares

 Additional paid-in capital

 Accumulated deficit

 (2,726
)

 (1,954
)

 TOTAL SHAREHOLDERS' DEFICIT

 (1,776
)

 (1,004
)

 TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT

the financial statements.

 FF- 5

 STATEMENTS OF OPERATIONS

 Year ended December 31

 2024

 2023

 thousands of NIS

 Operating expenses:

 Research and development

 General and administrative

 Operating loss

 (719
)

 (507
)

 Financial income

 Financial expenses

 (57
)

 (21
)

 Financial expenses, net

 (53
)

 (20
)

 (772
)

 (527
)

 The accompanying notes are an integral part
of the financial statements

 FF- 6

 STATEMENTS OF
CHANGES IN SHAREHOLDERS' EQUITY

 Ordinary

 shares

 Additional

 paid in

capital

 deficit

 Total

 shareholders'

 deficit

 thousands of NIS

 Balance as of January 1, 2023

 (1,427
)

 (606
)

 Contribution from related party (see note 5c)

 -

 -

 -

 -

 (527
)

 (527
)

 Balance as of December 31, 2023

 (1,954
)

 (1,004
)

 Issuance of ordinary shares (see note 6b.1)

 (*
)

 -

 -

 (*
)

 -

 -

 (772
)

 (772
)

 Balance as of December 31, 2024

 (2,726
)

 (1,776
)

 (*)
 Less than NIS 1 thousand

 The accompanying notes are
an integral part of the financial statements

 FF- 7

 STATEMENTS OF CASH FLOWS

 Year ended December 31

 2024

 2023

 thousands of NIS

 CASH FLOWS FROM OPERATING ACTIVITIES:

 (772
)

 (527
)

 Adjustments to reconcile net loss to net cash used in operating activities:

 Depreciation and amortization

 Non-cash interest

 Changes in operating assets and liabilities:

 Decrease (increase) decrease in other receivables

 (6
)

 Increase in loan to related party

 Increase in inventory

 (57
)

 (173
)

 (Decrease) increase in trade accounts payable

 (91
)

 Increase in payables to related parties

 Increase in other payables

 -

 Net cash used in operating activities

 (570
)

 (146
)

 CASH FLOWS FROM INVESTING ACTIVITIES:

 Loan to related party

 -

 (80
)

 Acquisition of property and equipment

 (5
)

 -

 Net cash used in investing activities

 (5
)

 (80
)

 CASH FLOWS FROM IN FINANCING ACTIVITIES:

 Deposit redemption

 -

 Contribution received from related party (see note 5c)

 -

 Proceeds from long-term loan

 Repayment of long-term loan

 (36
)

 (3
)

 Proceeds from loans from related parties

 -

 Net cash provided by financing activities

 Net decrease in cash and cash equivalents

 (5
)

 (2
)

 Cash and cash equivalents at beginning of year

 Cash and cash equivalents at end of year

 SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:

 Cash paid during the year for interest

 The accompanying notes are
an integral part of the financial statements

 FF- 8

 NOTES TO THE FINANCIAL STATEMENTS

data

 NOTE 1 – GENERAL

 A.
 REVOLTZ LTD (the "Company"), a private company, was incorporated in Israel on March 2021 and
its company number is 516356870.

 The Company engages in research, development,
and manufacturing of small electric transportation vehicles for urban environment. The development includes identifying the needs of specific
sectors and products to provide optimal solutions, including prototype development.

 B.
 The financial statements have been prepared on a going concern-basis which assumes the Company will be
able to realize its assets meets its obligations in the normal course of business for the foreseeable future.

 Since its inception, the Company has
devoted substantially all its efforts to research and development. The Company has incurred operating losses since its inception and expects
to continue to incur operating losses for the near-term. As of December 31, 2024, the Company had an accumulated deficit of 2,726 NIS.
The extent of the Company's future operating losses and the timing of becoming profitable are uncertain. Management expects the
Company to continue to generate substantial operating losses and to continue to fund its operations primarily through utilization of its
current financial resources and through additional raises of capital.

 Such conditions raise substantial doubts
about the Company's ability to continue as a going concern. Management's plan includes raising funds from outside potential
investors. However, there is no assurance such funding will be available to the Company or that it will be obtained on terms favorable
to the Company or will provide the Company with sufficient funds to meet its objectives. These consolidated financial statements do not
include any adjustments relating to the recoverability and classification of assets, carrying amounts or the amount and classification
of liabilities that may be required should the Company be unable to continue as a going concern.

 NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING
POLICIES

 a.
 Basis of presentation of the financial statements:

 The Company's financial statements
have been prepared in accordance with the United States generally accepted accounting principles (U.S. GAAP) as set forth in the Financial
Accounting Standards Board (the "FASB") Accounting Standards Codification (the "ASC").

 b.
 Use of estimates, assumptions and judgements:

 The preparation of financial statements
in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported in the
financial statements and accompanying notes. The Company's management believes that the estimates, judgment and assumptions used
are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported
amounts of assets and liabilities at the dates of the financial statements, and the reported amount of expenses during the reporting periods.
Actual results could differ from those estimates.

 c.
 Financial statements in New Israeli Shekels:

 The functional currency is the currency
that best reflects the economic environment in which the Company operate and conducts their transactions. The Company's functional
currency is the New Israeli Shekels (NIS).

 Accordingly, monetary accounts maintained
in currencies other than the NIS are remeasured into NIS at each reporting period end in accordance with ASC No. 830 "Foreign Currency
Matters". All transaction gains and losses of the remeasured monetary balance sheet items are reflected in the statements of operations
as financing income or expenses as appropriate.

 FF- 9

 NOTES TO THE FINANCIAL STATEMENTS

data

 NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

 d.
 Cash and cash equivalents:

 Cash equivalents are short-term highly
liquid deposits that are readily convertible to cash with original maturities of three months or less, at the date acquired, and investments
with maturities of longer than three months where the investment can be liquidated before the maturity date without a significant penalty.

 e.
 Inventory:

 Inventories consists of finished
goods and is stated at the lower of cost or net realizable value. Costs are computed under the first-in, first-out Method
("FIFO"). The cost of inventory includes all costs of purchase, and other costs incurred in bringing the inventories to
their present location and condition including shipment and freight costs. Net realizable value is determined as estimated selling
prices in the ordinary course of business, less reasonably predictable costs to sell. Valuation of inventories is based on currently
available information about expected recoverable value. The estimate is dependent upon factors such as market
trends, inventory ageing, and forecasted customer demands.

 f.
 Fair value of financial instruments:

 The accounting guidance for fair value provides a framework
for measuring fair value, clarifies the definition of fair value, and expands disclosures regarding fair value measurements. Fair value
is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction
between market participants at the reporting date. The accounting guidance establishes a three-tiered hierarchy, which prioritizes the
inputs used in the valuation methodologies in measuring fair value as follows:

 Level 1 — Quoted prices (unadjusted) in active
markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority
to Level 1 inputs.

 Level 2 — Observable inputs that are based on
inputs not quoted on active markets but corroborated by market data.

 Level 3 — Unobservable inputs are used when
little or no market data are available.

 The carrying amounts of cash and cash
equivalents, other receivables, loan to related party, trade accounts payables, loans from related parties, payables to related parties,
other payables and long-term loan approximate their fair value due to the short-term maturity of such instruments.

 g.
 Research and Development expenses:

 Research and development expenses are
recognized in the statements of operations when incurred. Research and development expenses consist of intellectual property, development
and production expenditures.

 h.
 Income Taxes:

 The Company accounts for income taxes in accordance with
ASC 740, "Income Taxes", which prescribes the use of the liability method whereby deferred tax asset and liability account
balances are determined based on differences between the financial reporting and tax bases of assets and liabilities and are measured
using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company provides a valuation
allowance, to reduce deferred tax assets to their estimated realizable value, if needed.

 The Company also accounts for uncertain tax positions under ASC 740. ASC 740 offers a two-step approach for recognizing and measuring
a liability for uncertain tax positions. The first step is to evaluate the tax position taken or expected to be taken in a tax return
by determining if the weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical merits,
the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. The second step is to
measure the tax benefit as the largest amount that is more than 50% likely to be realized upon ultimate settlement. As of December 31,
2024 and 2023, no liability for unrecognized tax benefits was recorded under ASC 740.

 FF- 10

 NOTES TO THE FINANCIAL
STATEMENTS

data

 NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

 i.
 Recently issued and not yet adopted accounting standards:

 In
December 2023, the FASB issued ASU 2023-09, Income taxes (topic 740): Improvements to Income Tax Disclosures. The guides require disclosure of
a tabular reconciliation, using both percentages and reporting currency amounts. Additional disclosers are required such as income taxes
paid, Income (or loss) from continuing operations before income tax expense (or benefit) disaggregated between domestic and foreign and
Income tax expense (or benefit) from continuing operations disaggregated by federal (national), state, and foreign. The guidance will
be effective for the Company for fiscal years beginning after December 15, 2025. Early adoption is permitted. Adoption of the new standard
will not have a material impact on the financial statements.

 NOTE
3 – INVENTORY

 2024

 2023

 Finished goods

 NOTE 4 – OTHER PAYABLES

 2024

 2023

 Advances from customers

 FF- 11

 NOTES TO THE FINANCIAL STATEMENTS

data

 NOTE 5 – RELATED PARTIES

 a.
 In support of the Company's efforts and cash requirements, the Company may rely on advances from
related parties until such a time that the Company can support its operations or attains adequate financing through sales of stock or
traditional debt financing. There is no formal written commitment for continued support by related parties.

 (i)
 Balances due from related parties:

 2024

 2023

 Loan to related party (see Note 5d)

 (ii)
 Balances owed to related parties:

 2024

 2023

 Loans from related parties (see Note 6b)

 Payables to related parties (see Notes 5b, 6b.1)

 1,055

 1,931

 b.
 In 2021, the Company entered into a consulting agreement with Mr. Amir Zaid, the controlling shareholder,
for the provision of full-time CEO services. Under the terms of the agreement, Mr. Zaid is entitled to a monthly fee of NIS 33. Other
than the compensation specified above, Mr. Zaid is not entitled to any additional remuneration or benefits. The unpaid monthly consulting
fees as of December 31, 2024 and 2023 were NIS 1,014 and NIS 759, respectively.

 c.
 During 2023, a related party (wholly owned by the controlling shareholder of the Company) transferred
an aggregate amount of NIS 129 to the Company. The funds received were classified as an investment in the Company.

 d.
 During 2023, the Company transferred an amount of NIS 80 to a related party. The loan bears interest in
accordance with the rate prescribed by Israeli Income Tax Regulations and does not include a repayment date. As of December 31, 2024,
the balance of the loan Principal Amount and accrued interest, was NIS 83.

 NOTE 6 – LOANS

 a.
 Long-term loan, net of current maturities:

 2024

 2023

 Loan from banks

 Current maturities

 (32
)

 (29
)

 b.
 Loans from related parties:

 1.
 On February 5, 2024, the Company signed a loan, investment and consulting agreement with L.I.A. PURE CAPITAL
LTD (hereinafter: "PURE"). According to the agreement, PURE will lead a group of investors that will lend the Company USD
200,000 in four equal monthly installments starting from February 2024.

 The term of the loan is one year or
until the completion of a first capital raise of no less than USD 700,000 (hereinafter – "Minimum Raise") (whichever
comes first). The loan will have seniority over any other Company debt and will bear annual interest at a rate of 8%.

 FF- 12

 NOTES TO THE FINANCIAL STATEMENTS

data

 NOTE 6 – LOANS
(Continued)

 As part of the agreement, PURE will
become a consultant to the Company in exchange for a monthly fee of USD 1,000, which will increase to USD 7,500 immediately upon the completion
of a USD 1 million capital raise, and/or the merger of the Company with another company that provides the Company with at least USD 1
million in liquid assets. The unpaid monthly consulting fees as of December 31, 2024 were NIS 41, presented as part of Payables to related
parties.

 Additionally, the Company issued to
PURE 5% of its ordinary shares at their par value. Furthermore, PURE was granted an option, for a period of one year, to invest USD 1
million in exchange for 45% of the Company's ordinary shares, provided that a Minimum Raise from another source has not been completed.
Lastly, the Company will allocate 10% of all its future proceeds for the repayment of the loan, until it is fully repaid or until the
Minimum Raise has been completed as stated above.

 Since the exercise price of the option
is denominated in U.S. dollars and the Company's functional currency is New Israeli Shekel, the option is not considered to be indexed
to its own stock in accordance with ASC Topic 815-40, "Contracts in Entity's Own Equity". Therefore, the option has been accounted
as derivative financial instruments and recorded at its fair value as a liability. The Company allocated the total proceeds received based
on the estimated fair value of the option, resulting in the recording of all proceeds to the option. Due to the requirement that the loan
must be repaid upon any fund raising, the Company classified it as a short-term loan in an amount of USD 200,000. As of December 31, 2024,
the balance of the Loan Principal Amount granted and accrued interest, was NIS 643. As of December 31, 2024, the Company remeasured the
option at fair value, which was determined to be immaterial.

 2.
 On July 28, 2022, Charging Robotics Ltd. ("CR Ltd."), a holder of 19.9% of the Company's
ordinary shares, entered into a convertible loan agreement with the Company pursuant to which CR Ltd. was required to loan an amount of
USD 60,000 (the "Loan Principal Amount") in the Company. In addition, CR Ltd. will provide an additional loan to the Company
in an amount of up to USD 340,000 (the "Additional Amount" and, together with the Loan Principal Amount, the "Total
Loan Amount"). The Total Loan Amount will carry interest at the minimum rate prescribed by Israeli law.

 The Total Loan Amount will be converted
into ordinary shares of the Company upon the occurrence of any of the following events (each, a "Trigger Event"):

 i)
 The consummation of funding by the Company of an aggregate amount of $1,000,000 at a pre-money the Company
valuation of at least $7,000 (in the form of Simple Agreement for Future Equity, equity or otherwise); or

 ii)
 The Company has generated an aggregate of $1,000,000 or more in revenue.

 In the event that a Trigger Event
will not occur on or prior to the 24-month anniversary of the date on which the Loan Principal Amount is actually extended to the Company,
the loan will be due and repayable by the Company to CR Ltd.

 As of December 31, 2024, the balance
of the Loan Principal Amount granted and accrued interest, was USD 64,000 (NIS 233). To date, no Additional Amounts have been funded.

 FF- 13

 NOTES TO THE FINANCIAL
STATEMENTS

data

 NOTE 7 – ORDINARY SHARES

 a.
 As of December 31, 2024 and December 31, 2023, the Company's share capital is as follows:

 December 31, 2024

 December 31, 2023

 Issued and

 Issued and

 Authorized

 Authorized

 Ordinary shares

 1,000,000

 105,260

 1,000,000

 100,000

 Each ordinary share is entitled to receive
the following rights: (i) the right to vote in any general meeting of the Company, (ii) the right to receive dividends, if and when declared
by the Board of Directors and (iii) the right to receive upon liquidation of the Company a sum equal to the nominal value of the ordinary
share, and if a surplus remains, to receive such surplus, subject to the rights conferred on any class of shares which may be issued in
the future.

 b.
 With respect to the share issuance to PURE, see Note 6b.1 above.

 NOTE 8 – TAXES ON
INCOME

 a.
 Corporate tax rates in Israel:

 The Israeli statutory corporate tax
rate was 23% in both 2024 and 2023. The Company's tax assessments since its inception are not deemed final.

 b.
 Deferred income taxes:

 Deferred income taxes reflect the net tax effects of temporary
differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax
purposes. Significant components of the Company's deferred tax assets are as follows:

 2024

 2023

 Deferred tax assets:

 Carry forward tax losses

 1,694

 Net deferred tax asset before valuation allowance

 1,694

 Valuation allowance

 (1,694
)

 (964
)

 Income tax benefit at the statutory tax rate

 -

 -

 In assessing the realization of deferred
tax assets, management considers whether it is more likely than not that all or some portion of the deferred tax assets will not be realized.
The ultimate realization of the deferred tax assets is dependent upon the generation of future taxable income during the periods in which
temporary differences are deductible and net operating losses are utilized. Based on consideration of these factors, the Company recorded
a full valuation allowance as of December 31, 2024.

 c.
 Net operating carry-forward losses for tax purposes:

 As of December 31, 2024, the Company's
carry-forward losses amount to approximately 1,694 of NIS which can be carried forward for an indefinite period.

 FF- 14

 (b) Exhibits

 See
Exhibit Index

 ITEM 16. FORM 10-K SUMMARY

 Not applicable

 Charging Robotics Inc.

 Index to Exhibits

 Exhibit No.

 Description

 3.1

 Certificate of Incorporation of the Company (included as Exhibit 3.1.1 to our Form 10-12G filed with the Securities and Exchange Commission on March 8, 2021, and incorporated herein by reference)

 3.2

 Amendment to Certificate of Incorporation of the Company (included as Exhibit 3.2 to our Form 10-12G filed with the Securities and Exchange Commission on March 8, 2021, and incorporated herein by reference)

 3.3

 Restated Certificate of Incorporation of the Company (included as Exhibit 3.1.3 to our Form 10-12G filed with the Securities and Exchange Commission on March 8, 2021, and incorporated herein by reference)

 3.4

 Amended and Restated Certificate of Incorporation of the Company (included as part of Exhibit A to our DEF 14C filed with the Securities and Exchange Commission on August 9, 2023, and incorporated herein by reference)

 3.5

 Amended
and Restated Certificate of Incorporation of the Company (included as part of Exhibit A to our DEF 14C filed with the Securities and
Exchange Commission on October 28, 2024, and incorporated herein by reference)

 3.6

 Bylaws of the Company (included as Exhibit 3.2.1 to our Form 10-12G filed with the Securities and Exchange Commission on March 8, 2021, and incorporated herein by reference)

 4.1*

 Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934

 10.1

 Charging Robotics, Inc. 2023 Equity Incentive Plan (included as Exhibit B-1 to our Information Statement on Schedule DEF 14C filed with the Securities and Exchange Commission on August 9, 2023, and incorporated herein by reference)

 10.2

 Securities Exchange Agreement (included as Exhibit 10.1 to our 8-K filed with the Securities and Exchange Commission on March 28, 2023, and incorporated herein by reference)

 16.1

 Letter from Elkana Amitai CPA, addressed to the Securities and Exchange Commission, dated March 12, 2025 (included as Exhibit 16.1 to our 8-K filed with the Securities and Exchange Commission on March 12, 2025, and incorporated herein by reference)

 19.1*

 Insider Trading Policy

 21.1

 List of Subsidiaries (included as Exhibit 21.1 to our Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 12, 2024, and incorporated herein by reference)

 31.1*

 Certification of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 and Rule 13a–14(a)/15d–14(a)

 31.2*

 Certification of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 and Rule 13a–14(a)/15d–14(a)

 32.1*

 Section 1350 Certification of the Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 32.2*

 Section 1350 Certification of the Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 101.INS*

 101.SCH*

 101.CAL*

 101.DEF*

 101.LAB*

 101.PRE*

 *

 Filed herewith

 SIGNATURES

 Pursuant to the requirements
of Section 13 and 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this Annual Report on Form 10-K to be signed
on its behalf by the undersigned, thereunto duly authorized on this 15 day of April, 2025.

 /s/ Hovav Gilan

(Principle Executive Officer)

 /s/ Gadi Levin

 Chief Financial Officer

 (Principal Financial and Accounting Officer)

 Pursuant to the requirements
of the Securities Act of 1934, this annual report on Form 10-K has been signed below by the following persons on behalf of the registrant
and in the capacities and on the dates indicated.

 Signature

 Title

 Date

 /s/ Hovav Gilan

 (Principle Executive Officer)

 /s/ Gadi Levin

 Chief Financial Officer

 (Principal Financial and Accounting Officer)

 /s/ Yakov Baranes

 Yakov Baranes

 /s/ Eliyahu Yoresh

 Eliyahu Yoresh

 /s/ Amitay Weiss

 Amitay Weiss

 /s/ Tali Dinar

 Tali Dinar

 0001459188 false FY true

 2024-06-30

 us-gaap: RelatedPartyMember

 us-gaap: RelatedPartyMember

 2023-04-07

 2023-04-07
 2023-04-07

 us-gaap: PrivatePlacementMember

 2023-11-22
 2023-11-22

 chev: RoboticsMember

 2021-04-24

 2021-04-01
 2021-04-24

 chev: RevoltzMember

 2022-07-28

 chev: RevoltzMember

 chev: XyloLoanMember

 chev: XyloLoanMember

 2022-01-01

 2023-04-04

 chev: XyloLoanMember

 chev: XyloLoanMember

 chev: ConsultingFeesToExecutiveOfficersMember

 chev: ConsultingFeesToExecutiveOfficersMember

 chev: DirectorsMember

 chev: DirectorsMember

 chev: XyloMember

 chev: XyloMember

 chev: ShareCapitalMember

 chev: ArticlesOfIncorporationMember

 chev: ArticlesOfIncorporationMember

 us-gaap: PreferredStockMember

 chev: ShareCapitalMember

 chev: ArticlesOfIncorporationMember

 chev: ArticlesOfIncorporationMember

 us-gaap: PreferredStockMember

 2023-04-04
 2023-04-04

 chev: AcquisitionAgreementMember

 us-gaap: InvestorMember

 us-gaap: RestrictedStockUnitsRSUMember

 2023-07-04
 2023-07-04

 us-gaap: WarrantMember

 chev: BGUOptionsMember

 2022-02-01
 2022-02-01

 chev: AcquisitionAgreementMember

 chev: AcquisitionAgreementMember

 us-gaap: PreferredStockMember

 us-gaap: PreferredStockMember

 us-gaap: MeasurementInputSharePriceMember

 us-gaap: MeasurementInputExercisePriceMember

 us-gaap: MeasurementInputExpectedDividendRateMember

 us-gaap: MeasurementInputRiskFreeInterestRateMember

 us-gaap: MeasurementInputExpectedTermMember

 us-gaap: MeasurementInputOptionVolatilityMember

 chev: JanuaryOneTwoThousandTwentyTwoMember

 chev: JanuaryOneTwoThousandTwentyTwoMember

 country: IL

 country: IL

 2023-03-01
 2023-03-31

 2025-01-31
 2025-01-31

 us-gaap: InvestorMember

 2025-01-15
 2025-01-15

 2025-03-06
 2025-03-06

 2025-03-23
 2025-03-23

 us-gaap: PrivatePlacementMember

 2025-03-23
 2025-03-23